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 Burkholderia cenocepacia is an opportunistic pathogen of humans that encodes 
two LuxR-type acylhomoserine (AHL) synthases and three LuxR-type AHL receptors. 
Of these, cepI and cepR are tightly linked and form a cognate synthase/receptor pair, as 
do cciI and cciR.  In contrast, CepR2 is unlinked from the other four genes, and lacks a 
genetically linked cognate AHL synthase gene.  In the first study, a CepR-binding site 
(cep box) was systematically altered to identify nucleotides essential for CepR activity in 
vivo and CepR binding in vitro. The consensus cep box determined from these 
experiments was used to screen the genome and identify CepR-regulated genes 
containing this site. Four new regulated promoters were found to be induced by OHL and 
required the cep box for induction and CepR binding. In the second study, the regulatory 
mechanism of CepR2 at two divergently transcribed genes predicted to direct the 
synthesis of secondary metabolites was investigated. These cepR2-linked genes were 
induced by OHL and required CepR2, indicating CepR2 acts as a repressor at these 
promoters and is antagonized by OHL. A lacZ reporter fused to the divergent promoters 
was used to confirm these hypotheses. Promoter resections and DNase I footprinting 
assays revealed a single cepR2 binding site located in the intergenic region upstream of 
both promoters and was required for CepR2-dependent regulation. An AraC homolog, 
CepS, encoded adjacent to cepR2, was found to be essential for expression of both 
promoters, regardless of the CepR2 status or OHL concentration.  CepS therefore acts 
downstream of CepR2 and CepR2 appears to function as a CepS antiactivator. 
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CHAPTER 1: EVOLUTION OF QUORUM SENSING SYSTEMS OF THE 
Burkholderia cenocepacia COMPLEX 
 
1.1. History, taxonomy and diversity of the Burkholderia genus 
1.1.1. History and taxonomy of the Burkholderia genus 
 
 The history of the Burkholderia genus is complex and still evolving, akin to its 
members, that are notorious for their metabolic diversity and genetic plasticity.  First 
described by Walter Burkholder (Cornell Plant Pathology) in the 1940s, isolates 
recovered from decaying onion bulbs were identified as the causative agent of soft rot in 
onions and later found to share 16S rRNA sequence similarity with Pseudomonads 
(Burkholder, 1950). Following the restructuring of the Pseudomonas genus based on 
rRNA-DNA hybridization and rRNA gene sequencing, seven species (P. cepacia, P. 
solanacearum, P. pickettii, P. gladioli, P. mallei, P. pseudomallei, and P. caryophylli), 
were transferred to the newly named Burkholderia genus (Yabuuchi et al., 1992).  
 
 A group of human opportunistic pathogens previously known as ‘eugonic 
oxidisers group 1’, was shown to represent the same species, B. cepacia (Coenye & 
Vandamme, 2003). Through the use of polyphasic techniques, most B. cepacia strains 
were demonstrated to actually represent a complex of closely related species that could 
be separated into phenotypically similar genomic groups, collectively known as the B. 
cepacia complex (Bcc) (Fig. 1.1). The Bcc is comprised of species that share a high 
similarity at the 16S rRNA level (> 97%) and only moderate DNA-DNA hybridization 
(30-60%).  Given the limitations of 16s rRNA sequence to resolve below the species 
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level, alternative molecular genotyping approaches with objective and greater resolving 
power were developed to delineate the relationships between the closely related Bcc 
species (Vandamme & Dawyndt, Martens et al., 2008). Multilocus sequence analysis 
(MLSA), which compares the divergence of seven housekeeping genes located on the 
first and second chromosome, recA gene sequence, and whole-genome sequence analysis 
have been successful in classifying novel species within this complex. The recent 
establishment of two taxon K strains, B. contaminans and B. lata, as distinct species, has 
expanded the current structure of the Bcc group to 17 validly described species (Vanlaere 
et al., 2009). As whole-genome sequence for additional representative and candidate 
strains becomes available, the taxonomy of this diverse group is expected to continue to 
evolve (Vanlaere et al., 2009). 
 
1.1.2. Ecological diversity of the Burkholderia genus 
 
 This diverse genus is currently comprised of 70 species that are ubiquitous in 
nature and have been isolated from a wide array of ecological niches ranging from water 
and soils to the respiratory tracts in humans (see http://www.bacterio.cict.fr/). In some 
cases, Burkholderia bacteria can form opposing interactions depending on the host 
colonized, functioning as either a pathogen or a symbiont (Fig 1.1). The majority of 
Burkholderia species are non-pathogenic soil bacteria and several form beneficial 
interactions with plants, including nitrogen fixation and nodulation in legumes by B. 
caribensis, B. kururienis, B. nodosa, and B. tuberum and biocontrol of soil-borne plant 
pathogens. Some species have been introduced into agricultural crop soils as biocontrol 
agents (Coenye & Vandamme, 2003, Bontemps et al., 2010, Gyaneshwar et al., 2011).  
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 Several members of this genus have been identified as important pathogens in 
cystic fibrosis (CF) patients, causing chronic and severe lung infections 
(Mahenthiralingam et al., 2005). The intrinsic antibiotic resistance of Burkholderia 
species severely limit therapeutic options and can lead to persistent colonization.  In some 
cases, the infection progresses to a condition described as ‘cepacia syndrome,’ which is 
marked by a progressive and rapid deterioration of lung function and is associated with 
increased mortality rates. While all Bcc species have been isolated from CF sputum, B. 
cenocepacia and B. multivorans strains predominate (McDowell et al., 2004). The best 
characterized is the virulent B. cenocepacia J2315 strain that represents the 
Edinburgh/Toronto type 12 (ET12) intercontinental epidemic strain (Mahenthiralingam et 
al., 2002). 
 
  Some Burkholderia species can form both deleterious and beneficial interactions 
depending on the host it has colonized. In the lungs of CF patients, new strains of B. 
vietnamensis continue to emerge. Sequence analysis have identified several 
environmental isolates that are identical to CF outbreak strains, showing this globally 
distributed soil bacterium may be well adapted to human infection (McDowell et al., 
2004). In contrast, B. vietnamensis isolates have been recovered from the rhizosphere of 
rice species and shown to function in nitrogen fixation for the plant (Chen et al., 2003). 
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Figure 1.1. 16S rRNA gene phylogeny of known Burkholderia species, including proposed new 
Burkholderia species.  The genus can be divided into two groups; group A contains most of the plant-
associated species and all currently known legume nodulators within the genus. Group B contains all 
known phytopathogens and species that may cause disease in humans and animals. Candidate species are in 
red. Modified from (Gyaneshwar et al., 2011). 
!!
!!
!! !!
!!
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1.2. Genomics of the B. cepacia complex 
 
 The importance of Burkholderia cepacia complex species as human pathogens 
has prompted the sequencing of numerous genomes within this genus. Nine sequencing 
projects have been completed, including four B. cenocepacia strains J2315, AU1054, 
HI2424, and MC0-3, all of which were isolated from CF patients (available at the Sanger 
Institute; http://sanger.ac.uk/ Projects/Microbes/).  Additionally, several environmental 
strains have been completed recently, including B. vietnamensis str. G4, B. multivorans 
ATCC 17616, and two B. cepacia strains, 383 and AMMD (all can be found at 
http://www.jgi.doe.gov/JGI_microbial/html/index/ html). Presently, the genome 
sequences of 18 strains from 10 Bcc species are publically available 
(http://pathema.jcvi.org/cgibin/Burkholderia/PathemaHomePage. cgi).  
 
Burkholderia species possess some of the largest, most complex genomes, 
ranging in size from 6.2 to 9.73 Mbp. They are characterized by a high G+C content 
(~67%), multireplicon structure, numerous gene duplications, insertion sequences, and 
mobile elements that contribute to the high frequency of genetic rearrangement 
characteristic of species within this group. The genomes of four isolates of B. 
cenocepacia have been sequenced in their entirety while additional genomes are currently 
being sequenced (NCBI, 2011).  All four sequenced genomes have three circular 
chromosomes that vary in size between 0.88 and 3.9 MB in length,.  Chromosome 3 of 
strain J2315 was recently found to be curable (Agnoli et al., 2012), and should therefore 
be considered a plasmid. Strains J2315 and HI2424 also have one plasmid, 93 KB and 
165 KB in length respectively. The remarkable ability to adapt to diverse ecological 
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habitats is attributed to the metabolic diversity and genetic plasticity of its genome 
(Holden et al., 2004). Analysis of sequenced Bcc genomes estimates that more than 10% 
of sequence has been acquired through horizontal gene transfer. Comparative analysis of 
four B. cenocepacia strains shows significant differences in genomic content and 
highlights the extent of genetic plasticity even at the species level. The sequenced 
genome of J2315 reveals it contains approximately 21% unique DNA in comparison with 
the other B. cenocepacia strains, including a 0.93 kb plasmid found only in J2315 and 
HI2424, 14 genomic islands and numerous mobile genetic elements (Holden et al., 2009). 
In addition to the vast chromosomal modifications by foreign DNA, there is evidence that 
genes are transferred between Bcc species. Some of these genomic islands unique to the 
ET12 lineage share similarity with islands in other Bcc species and promote survival and 
pathogenesis in the CF lung ((Mahenthiralingam et al., 2001, Baldwin et al., 2004). 
 
 Bcc strains exhibit a high degree of antibiotic drug resistance, with some strains 
utilizing penicillin G as a carbon source (Beckman & Lessie, 1979). This extensive drug 
resistance severely limits infection control strategies and is therefore considered as 
virulence factors of this pathogen. Burkholderia species possess multiple mechanisms for 
antibiotic resistance including efflux pumps, degradative enzymes, low cell membrane 
permeability, and antibiotic target modification. The genome of J2315 encodes numerous 
efflux pump systems belonging to six families associated with drug resistance, at least 
four β-lactamases, and evidence of a non-synonymous substitution in the dihydrofolate 
reductase (dfrA) gene targeted by trimethoprim, all of which contribute to an incredible 
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intrinsic resistance to a wide range of clinically-relevant drugs (Holden et al., 2009).                       
. 
 
1.3. AHL-quorum sensing systems in Proteobacteria 
1.3.1. Quorum sensing systems 
 
  Bacteria in the environment exist within complex communities that rely on 
various signaling mechanisms to perceive their surroundings and efficiently modulate 
gene expression for rapid adaptation to ever changing conditions. Quorum sensing (QS) 
is one type of communication system that enables bacteria to coordinate the synthesis of 
genes in a density dependent manner in response to an endogenously produced signal 
molecule, N-acyl-homoserine lactone (AHL), also described as an autoinducer. This 
simple AHL-driven system, first described for the regulation of bioluminescence genes in 
Vibrio fischeri, is composed of a signal synthase, LuxI, and a transcription regulator, 
LuxR (Hastings & Nealson, 1977). At low cell density, basal level expression of LuxI 
results in a minimal production of N-oxohexanoyl-homoserine lactone (OHHL) that 
accumulates extracellularly. Dependent upon cell density, external diffusion constraints, 
and conditions affecting signal stability, the OHHL concentration reaches a critical 
threshold and diffuses back across the cytoplasmic membrane. The autoinducer is bound 
by newly synthesized LuxR protein and stable LuxR-OHHL complexes accumulate. 
Active LuxR-OHHL complexes recognize a 20-bp dyad sequence in the promoter region, 
designated the lux box, and up-regulate gene expression of the lux operon (Boyer & 
Wisniewski-Dyé, 2009).   
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 AHL synthases direct the synthesis of N-acylhomoserine lactones from an acyl-
ACP and S-adenosylmethionine. AHLs vary in fatty acid chain length (4-18 carbons) and 
modifications at the third carbon (either unsubstituted or substituted with hydroxyl, oxo 
groups, or acyl chain desaturation) (Eberhard et al., 1981).  This variation in the fatty 
acid chain is believed to provide specificity in recognition between the LuxR homolog 
and its cognate AHL (Nasser & Reverchon, 2007). 
 
1.3.2. Phylogenetic distribution and evolution of quorum sensing systems 
 
 AHL-based QS systems are unique to the Proteobacteria phylum. Analysis of 265 
proteobacterial genomes identified genes for QS systems in 68 species. Within these 
bacteria, QS has been described to regulate diverse functions that play a role in symbiosis 
and pathogenesis such as bioluminescence, nodulation, motility, biofilm formation and 
production of virulence factors (Whitehead et al., 2001, Case et al., 2008). 
 
 Phylogenetic analysis of LuxI/R family members show they are subdivided into 
two groups with one group restricted to the γ-proteobacteria (family B), and the other 
more widely distributed across the α, β, and γ classes (family A) (Lerat & Moran, 2004, 
Case et al., 2008). While both groups share similar functions, the divergence of aligned 
amino acid sequences suggests they are not paralogous but arose through speciation 
events. Neighbor-joining tree reconstructions of the LuxI and LuxR homologs within 
their respective groups reveal the two trees are globally congruent, indicating co-
evolution of the AHL synthase and regulator (Fig 1.2) (Lerat & Moran, 2004). 
Furthermore, the agreement between the SSU rRNA and the LuxI/R trees indicates an 
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ancient evolution of the QS mechanism within these bacteria (Lerat & Moran, 2004, Case 
et al., 2008).  
 
 In many lineages, the genes for the inducer and regulator are genetically linked and 
retain pairwise functional relationships. This is not always the case, as in A. tumefaciens, 
whose traR and traI genes are separated by more than 60 kb on the octopine-type plasmid 
(Fuqua & Winans, 1994).   In cases where lateral transfer events lead to the movement of 
QS genes across bacterial species (Boucher et al., 2003, Lerat & Moran, 2004), this 
contiguous arrangement may ensure that the QS system remains intact, thereby retaining 
regulatory ability that can be harnessed by the recipient cell.  
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Figure 1.2. (A) Tree based on the protein alignment of the LuxI members of family A. (B) Tree 
based on the protein alignment of the LuxR members of family A. (C) Tree based on the protein 
alignment of the LuxI members of family B. (D) Tree based on the protein alignment of the LuxR 
members of family B. Species abbreviations as in table 1. Different phylogenetic methods yielded 
the same topology, and we present trees obtained using NJ and γ correction. Asterisks (*) indicate 
paralogous copies. The number sign (#) indicates nodes with bootstrap values less than 50%. 
Modified from (Lerat & Moran, 2004). 
 
1.3.3. LuxR-type solo regulators  
 
LuxI family LuxR family 
Family A 
Family B 
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 Of the 68 proteobacterial genomes encoding a complete QS system, 45 harbor 
genes encoding LuxR homologs that exceed the number of genes for predicted AHL 
synthases. While the cognate signal for these additional regulators is not immediately 
clear, it is very plausible that they can perceive the AHL signal produced by the host 
synthase. In cells that possess at least one complete AHL QS system, these additional 
LuxR homologs, also described as LuxR solos, may be integrated with the native QS 
regulatory network and function to finely modulate AHL signaling within the cell. QscR, 
in Pseudomonas aeruginosa, closely interacts with the two native QS systems, LasI/R and 
RhlI/R, to coordinate temporal regulation of a number of virulence factors, including 
production of rhamnolipids, elastases, and biofilm formation (Lequette et al., 2006). In 
some organisms, the luxR-type gene is not accompanied by an AHL synthase gene. These 
QS regulators are predicted to perceive AHL signals produced other bacteria. SdiA, 
encoded by Escherichia coli and Salmonella enterica sv. Typhimurium, has been shown 
to respond to several exogenous AHL species (Ahmer, 2004, Yao et al., 2006, Janssens et 
al., 2007). 
 
1. 4. Quorum Sensing in B. cepacia complex species 
 
1.4.1. Quorum sensing genes in Bcc species 
 
 Of the BCC genomes that have been analyzed, members of the B. cepacia complex 
encode genes for the CepI/R QS system. The genes for CepI and CepR proteins are 
highly conserved in Bcc species, indicating that this system is important for the 
successful persistence in the diverse habitats of the Bcc species (Table 1.1). CepI and 
CepR show the highest similarity (64% and 67%, respectively) to the SolIR quorum 
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sensing genes in Ralstonia solanacearum. CepI in B. cenocepacia K56-2 produces two 
AHL signals, N-octanoyl-L-homoserine lactone (Coenye et al.) and N-hexanoyl-L-
homoserine lactone (HHL) in a 10:1 ratio (Huber et al., 2001).  Expression of the cepI 
gene is controlled from a 20-bp cep box that partially overlaps the -35 region of the 
promoter. The product of the divergently transcribed gene, CepR, positively regulates 
cepI expression at this site upon perception of OHL at high cell density (Fig 1.3) 
(Weingart et al., 2005). 
 
 Some members of the complex also carry genes for an additional QS system.  B. 
vietnamensis expresses a BviR protein which regulates gene expression in response to 
decanoyl-homoserine lactone (DHL) and 3-oxodecanoyl-homoserine lactone (ODHL) 
that are produced by the AHL synthase, BviI (Conway & Greenberg, 2002). Several B. 
cenocepacia strains harbor a second system, CciI/R, encoded on a pathogenicity island 
that was likely acquired through horizontal gene transfer (Baldwin et al., 2004). CciR 
responds to HHL produced by CciI and is reported to negatively regulate several genes 
within the CepR regulon, thereby acting to partially antagonize CepR-dependent function 
(Fig. 1.3) (O'Grady et al., 2009).  
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Figure 1.3. CepI/CepR quorum sensing system in Burkholderia cenocepacia. CepI directs the synthesis of 
OHL which is then bound by the transcriptional regulator, CepR, to regulate expression of genes at high 
cell density.  CepR-OHL induce or repress target genes through DNA binding at the cep box. CciI produces 
HHL, which is recognized by CciR.  CciR-HHL negatively regulates several genes, including cciI 
expression which initiates negative feedback regulation of the CciIR regulon (Eberl, 2006; O'Grady et al., 
2009). 
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 Many of the bacterial genomes within the Burkholderia genus contain at least one 
additional LuxR homolog. The animal pathogens, B. mallei and B. pseudomallei, both 
possess at least two LuxR homologues in addition to multiple complete QS circuits. 
These regulators exhibit relaxed AHL specificity and recognize several endogenous 
signal molecules (Case et al., 2008). B. cenocepacia strains encode a single LuxR solo, 
CepR2, that has weak similarity to CepR (38% identity). CepR2 has been found to 
negatively regulate genes encoding nearby divergent non-ribosomal peptide synthase 
operons, as well as several virulence factors within the CepR regulon (Malott et al., 2009, 
O'Grady et al., 2009). 
1.4.2. Regulation of genes by CepIR and CciIR in B. cenocepacia  
 
 The CepI/R and CciI/R systems regulate the production of proteases, chitinases, 
and lipases, swimming and swarming motility, biofilm formation and maturation, as well 
as components of efflux pumps, lectins, pili and type II, III and IV secretion systems 
(Lewenza et al., 1999, Huber et al., 2001, Lewenza & Sokol, 2001, Aguilar et al., 2003, 
Eberl, 2006).  
 
 CepR is a global regulator and functions primarily as an activator of gene 
expression, including the transcription of cepI and cciIR operons (Fig 1.3). CciR has been 
shown to reciprocally regulate many CepR-dependent genes, thus providing a regulatory 
feedback of QS-dependent expression (Malott et al., 2005). The LuxR solo, CepR2, has 
been shown to negatively regulate several genes within the CepR regulon, including an 
efflux system and protease (Malott et al., 2009). Interestingly, CepR2 was demonstrated 
to activate a luxI promoter in an AHL independent manner, suggesting a novel 
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mechanism may exist for this LuxR-type regulator (Malott et al., 2009). 
 
 To date, several studies have revealed many targets of the CepI/R regulon. 
However, most of these are likely regulated indirectly by CepR. Deciphering the CepR 
binding site was deemed crucial for identifying new genes directly under the control of 
the regulator and is the focus of Chapter 2.  
1.4.3. Quorum sensing-mediated pathogenesis in B. cenocepacia 
 Pulmonary infections with B. cenocepacia strains typically occur in the later 
stages of CF and follow P. aeruginosa colonization (Coenye & Vandamme, 2003).  
Recovery of OHL, the principle autoinducer produced in B. cenocepacia, from CF lung 
tissue and sputum samples, established the use of quorum sensing in B. cenocepacia 
pathogenesis in CF pulmonary infections (Eberl, 2006). CepI and CepR mutant strains 
demonstrated reduced virulence in rat and mouse agar bead infection models of chronic 
lung infection (Sokol et al., 2003). The functional significance of this system is further 
underscored by the fact that the QS circuit and activity remains intact, while mutations 
accumulate in genes involved in late stage infections including motility, iron acquisition, 
and O-antigen biosynthesis (McKeon et al., 2011). Two genes involved in oxidative 
stress response, katC and sodB, were found to be down-regulated in cepR mutants 
compared to wild type and are predicted to play a role in intracellular survival within 
macrophages and respiratory epithelial cells (O'Grady et al., 2009). However, this would 
require a quorum is attained and the lipid-soluble autoinducer is permitted to reach 
sufficient concentrations within the host cell. 
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1.5. 
Mechanism of LuxR-type regulators 
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1.5.1. Classification of LuxR homologues 
 
  The LuxR family proteins feature two domains, with the NTD serving to 
recognize the AHL and the CTD recognizing nucleotides within the DNA binding site 
(Whitehead et al., 2001, Pappas et al., 2004). Amino acid alignments show a low 
sequence similarity overall (~25%); however, several residues making critical contacts in 
the NTD and CTD are highly conserved (Vannini, et al., 2002).   
 
 Proteins within the LuxR family are grouped into four classes based on interactions 
with AHL and their multimeric properties (Fig. 1.4) (Stevens et al., 2011). Classes I-III 
proteins are transformed into an active state upon perception of their cognate signal also 
described as the holo-form state. Class I regulators, such as TraR from Agrobacterium 
tumefaciens, binds its cognate signal at a buried hydrophobic pocket that serves as a 
structural scaffold during peptide synthesis. Apo-TraR is unable to dimerize and is 
targeted for rapid proteolysis by Clp and Lon proteases (Zhu & Winans, 1999). CepR 
binds OHL during protein synthesis and is similarly required for proper folding and 
transcription activation (Weingart et al., 2005, Wei et al., 2011). LuxR is a representative 
of Class II regulators that requires AHL for protein folding, but unlike Class I proteins, 
AHL binding is reversible and OOHL can be diluted away from the binding domain 
without loss of protein stability. While, nanomolar OHHL concentrations are inhibitory 
to LuxR, the phenotype can be rescued with additional inputs of the autoinducer signal 
(Urbanowski et al., 2004). Class III regulators, such as QscR in P. aeruginosa, are stable 
in the absence of AHL but require binding of the signal for dimerization and 
transcriptional activation (Yang et al., 2009).  
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 In contrast, Class IV regulators, such as EsaR from Pantoea stewartii, are active in 
the absence of their signal, to bind as dimers to operator sites within the DNA (Fig. 1.4) 
(Minogue et al., 2005). Binding the AHL molecule decreases affinity of the LuxR protein 
for the DNA and antagonizes its regulatory function (Patankar & González, 2009, 
Subramoni & Venturi, 2009). Only a few members have been characterized, including 
YenR and EsaR, and are reported to repress to their target genes at low cell density when 
AHL levels are minimal (Castang et al., 2006, Tsai & Winans, 2011). Differences in 
structural elements differentiate γ-proteobacteria class IV proteins from their holo-active 
counterparts. Amino acid sequence analysis of members of this class reveals an extended 
linker region between the NTD and an extended C-terminus.  
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Figure 1.4 Classification of LuxR homologues. The cognate AHL for a given LuxR homologue 
is represented by a black diamond. White and grey diamonds represent non-cognate AHLs. 
Adapted from (Stevens et al., 2011). 
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 With a significant number of LuxR homologs characterized over the past few 
decades, phylogenetic analysis of these genes has begun to yield insights beyond 
sequence relatedness and enable predictions about possible regulatory mechanisms for 
newly described QS regulators.  LuxR-type proteins whose activity is stimulated upon 
perception of their cognate AHL (class I-III), are widely distributed across the 
Proteobacteria (α, β, γ) (Fig. 1.2b), yet cluster into a distinct group, described as Family 
A in this text. In contrast, apo-active QS regulators, whose activity is antagonized upon 
binding their AHL (class IV), cluster separately from their counterparts in Family B (Fig. 
1.2d). Until recently, this intriguing group of apo-active regulators has been described 
only in organisms within the γ-proteobacteria. However, as the search for novel LuxR 
homologs continues, facilitated by the increasing number of sequenced genomes, 
examples of apo-active regulators are emerging in other Proteobacterial classes. VjbR, a 
LuxR-type protein in the α-proteobacterial organism, Brucella melitensis, is reported to 
regulate genes for flagella motility and type IV secretion at low cell density and its 
activity is antagonized through binding its cognate AHL (Delrue et al., 2005). Another 
homolog in the β-proteobacterium, B. cenocepacia, CepR2, regulates secondary 
metabolite genes in the absence of OHL and is the focus of Chapter 3. While the 
correlation between phylogeny and biological function has been well established, it 
remains to be seen whether this relationship will extend to regulatory mechanistic 
function, as well.  
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Chapter 2: 1Saturation mutagenesis of a CepR binding site as a means 
to identify new quorum-regulated promoters in Burkholderia 
cenocepacia 
 
2.1 Abstract 
 
 Burkholderia cenocepacia is an opportunistic pathogen of humans that encodes two 
genes that resemble the acyl-homoserine lactone synthase gene luxI of Vibrio fischeri and 
three genes that resemble the acyl-homoserine lactone receptor gene luxR. Of these, CepI 
synthesizes octanoyl-homoserine lactone (OHL), while CepR is an OHL-dependent 
transcription factor. In the current study we developed a strategy to identify genes that are 
directly regulated by CepR. A CepR binding site (cep box) was systematically altered 
upstream of a target promoter to identify nucleotides that are essential for CepR activity 
in vivo and for CepR binding in vitro. Thirty-four self-complementary oligonucleotides 
containing altered cep boxes were constructed, and binding affinity was measured for 
each. These experiments allowed us to identify a consensus CepR binding site. I show 
that purified CepR induces a bend in a DNA fragment containing this consensus 
sequence. Several hundred similar sequences were identified, some of which were 
adjacent to probable promoters. Dr. Ana Lidia Flores-Mireles fused these 13 promoters to 
a reporter gene with and without intact cep boxes. This allowed her to identify four new 
regulated promoters that were induced by OHL, and that required a cep box for induction. 
In collaboration with Dr. Flores-Mireles, we show that expression of all four CepR 
and OHL-dependent promoters could be reconstituted in Escherichia coli. I then 
confirmed purified CepR-OHL complexes bound to each of these sites in 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Wei, Y., Ryan, G.T., Flores-Mireles, A.L., Costa, E.D. Scheneider, D.J., and Winans, S.C. 
(2011) Saturation mutagenesis of a CepR binding site as a mean to identify new quorum-
regulated promoters in Burkholderia cenocepacia. Mol Microbiol 79(3):616-632.   
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electrophoretic mobility shift assays. Furthermore, I found that seven promoters 
containing non-symmetric putative cep boxes, identified by Chambers et al., 2006 as 
direct targets of CepR, were not bound by the purified regulator. 
 
2.2 Introduction  
 
 The genus Burkholderia encompasses a fascinating collection of diverse β-
proteobacteria (Coenye and Vandamme, 2003). This genus includes over 50 species, 
some of which are potentially useful in bioremediation, while other members are capable 
of forming nitrogen-fixing root nodules with legumes (Chen et al., 2003; Bontemps et al., 
2010). Some members protect host plants against fungal pathogens, while others are 
themselves pathogenic against plants, animals and humans (Coenye and Vandamme, 
2003; Jones and Webb, 2003). Seventeen pathogenic species are members of the 
Burkholderia cepacia complex, or BCC (Vandamme et al., 1997; Vanlaere et al., 2008; 
2009), two of which are described by the Center for Disease Control as category B select 
agents (Godoy et al., 2003). 
 Burkholderia cenocepacia, previously known as B. cepacia genomovar III 
(Vandamme et al., 2003), is recognized as an opportunistic pathogen of humans and is a 
particular threat to cystic fibrosis (CF) patients (Vandamme et al., 1997; 
Mahenthiralingam et al., 2005). Colonization of the CF lung by B. cenocepacia  
(Vandamme et al., 2003) tends to occur in patients already infected with Pseudomonas 
aeruginosa, another opportunistic pathogen of the CF lung (Vandamme et al., 1997; 
Jones and Webb, 2003). An infection caused by both organisms can result in serious 
clinical complications. B. cenocepacia strains are resistant to most antibiotics, making 
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them virtually impossible to eradicate (Nzula et al., 2002). Infections with B. 
cenocepacia may have variable clinical outcomes ranging from asymptomatic carriage to 
a sudden fatal deterioration in lung function (Mahenthiralingam et al., 2005). 
 Four strains of B. cenocepacia have been sequenced in their entirety, one of which 
is described in a publication (Holden et al., 2009). The Joint Genome Institute is 
currently sequencing nine additional strains (http://www.jgi.doe.gov/genome-projects/). 
All four sequenced isolates have three circular chromosomes that vary in size between 
3.9 and 0.88 MB in length. The third chromosome has been found to be a curable and is 
considered a plasmid (Agnoli et al., 2012). Strains J2315 and HI2424 also have one 
plasmid, 93 KB and 165 KB in length respectively. 
 Many or possibly all Burkholderia spp. encode at least one regulatory system that 
resembles the LuxR and LuxI proteins of Vibrio fischeri, where LuxI synthesizes an acyl- 
homoserine lactone (AHL)-type pheromone, also called an autoinducer, and LuxR is an 
AHL-dependent transcriptional regulator (Eberhard et al., 1981; Engebrecht and 
Silverman, 1984; Choi and Greenberg, 1992). Regulatory systems of this family are 
found in countless proteobacteria, where they are thought to allow individual bacteria to 
coordinate their physiology with their siblings. Collectively, these systems regulate 
diverse processes, including pathogenesis, biofilm formation, bacterial conjugation and 
the production of antibiotics and other secondary metabolites (Whitehead et al., 2001). In 
general, target genes are transcribed preferentially at population densities high enough to 
favor AHL accumulation (Eberhard et al., 1991), a phenomenon referred to as quorum 
sensing (Fuqua et al., 1994). Burkholderia thailandiensis has three such systems, one of 
which is implicated in cell aggregation, while another is required for antibiotic 
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production (Chandler et al., 2009; Duerkop et al., 2009). A plant growth promoting 
isolate of Burkholderia ambifaria uses quorum sensing to regulate the production of the 
anti-fungal compound pyrrolnitrin (Schmidt et al., 2009). 
 LuxR-type proteins have two domains, an N-terminal pheromone binding domain 
and a C-terminal DNA binding domain (Pappas et al., 2004). Purified LuxR, TraR of 
Agrobacterium tumefaciens and LasR of P. aeruginosa, when complexed with their 
respective AHLs, bind with high specificity to recognition sequences (referred to as lux, 
tra or las boxes, respectively) that are found at target promoters (Zhu and Winans, 1999; 
Schuster et al., 2004; Urbanowski et al., 2004). LasR is also able to bind to sequences 
that have no obvious resemblance to canonical las boxes. A few members of this family 
bind DNA only in the absence of AHLs (Cui et al., 2005; Fineran et al., 2005; Minogue 
et al., 2005; Castang et al., 2006; Sjoblom et al., 2006). 
 Burkholderia cenocepacia J2315 encodes three LuxR homologues and two LuxI 
homologues (Lewenza et al., 1999; Malott et al., 2005; 2009). Among these, CepR and 
CepI appear to be well conserved within the BCC (Venturi et al., 2004). CepI 
synthesizes primarily octanoyl-homoserine lactone (OHL), and lower levels of hexanoyl-
homoserine lactone (Lewenza et al., 1999; Gotschlich et al., 2001; Huber et al., 2001; 
Aguilar et al., 2003a). Null mutations in cepI or cepR increased the production of the 
siderophore ornibactin, and decreased the production of secreted lipases and 
metalloproteases ZmpA and ZmpB (Lewenza et al., 1999; Lewenza and Sokol, 2001; 
Sokol et al., 2003; Kooi et al., 2006). CepI and CepR are also required for swarming 
motility and biofilm formation (Huber et al., 2001) and for pathogenicity in several 
animal models (Kothe et al., 2003; Sokol et al., 2003). B. cenocepacia also expresses the 
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CciI and CciR proteins, which are encoded on a genomic island called cci (cenocepacia 
island), that is associated with epidemic strains (Malott et al., 2005). The CepIR and 
CciIR systems extensively interact, in that CciR negatively regulates cepI, while CepR is 
required for expression of the cciIR operon (Malott et al., 2005). Transcriptional profiling 
studies indicate that CepR and CciR regulate many of the same genes, but do so in 
opposite ways (O’Grady et al., 2009). B. cenocepacia also encodes an orphan LuxR 
homologue called CepR2, which represses a cluster of genes that may direct production 
of an antibiotic or other secondary metabolite (Malott et al., 2009). 
 In addition to transcriptional profiling several other approaches have been used to 
identify genes whose expression is influenced by CepR and/or OHL. In one study, the 
proteome of a wild-type B. cenocepacia was compared with that of a cepR mutant. Fifty-
five proteins were found to be differentially expressed in the two strains, approximately 
10% of all detected proteins (Riedel et al., 2003). In a second study, fragments of a B. 
cepacia strain were cloned into a promoter trap plasmid and introduced into an E. coli 
strain that expressed CepR (Aguilar et al., 2003b). Twenty-eight promoter fragments 
were identified as being induced by OHL, and in all cases, induction required CepR. In a 
third study, a library of B. cenocepacia DNA fragments were introduced into a plasmid 
containing a promoterless luxCDABE operon (Subsin et al., 2007). That study identified 
58 OHL- inducible promoters and 31 OHL-repressible promoters. Regulation of nine of 
these genes required CepR, while the others were not tested. Seven OHL-inducible genes 
were identified by screening a library of lacZ fusions (Weingart et al., 2005). Induction 
of all of these genes required CepR. Purified CepR-OHL complexes bound with high 
affinity and specificity to specific DNA sequences at two target promoters (Weingart et 
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al., 2005). These binding sites contained a 16 nucleotide imperfect dyad symmetry and 
were centered approximately 44 nucleotides upstream of the transcription start sites. 
These two sites are to date the only experimentally confirmed CepR binding sites. Most 
of the studies described above do not distinguish whether a target promoter is controlled 
by CepR directly or indirectly. CepR could regulate a promoter indirectly, for example, 
by directly regulating an unknown regulatory gene whose product directly regulates that 
promoter. Alternatively, a CepR mutation might perturb cellular physiology in such a 
way that various promoters are affected by secondary effects. 
 To date, the most comprehensive study attempting to define the optimal CepR 
binding site was done by Chambers, Sokol and colleagues (Chambers et al., 2006), who 
approached this question with an impressive combination of genetics and bioinformatics. 
Mutagenesis of the known CepR binding site within the cepI promoter completely 
abolished induction (Chambers et al., 2006). The promoters of six genes known to be 
induced by OHL were used to formulate a consensus CepR binding motif (Chambers et 
al., 2006). This information was used to test eight additional candidate promoters, six of 
which were CepR- regulated. Ultimately, 10 inducible promoters were used to refine the 
consensus sequence, and 57 possible CepR binding sites were identified upstream of 
various genes. 
 The consensus motif identified in the Chambers study included the sequence CTG-
N10-CAG, which has dyad symmetry. However, several other bases in the consensus did 
not preserve this symmetry, and some of those non-symmetric bases were said to be 
highly conserved (Chambers et al., 2006). The partial dyad symmetry suggests that CepR 
binds DNA as dimer and that the two DNA binding domains have rotational symmetry. 
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Although we have no proof of this, structural studies of a related protein support this idea 
(Vannini et al., 2002; Zhang et al., 2002). Several other LuxR-type proteins are thought 
to decode dyad symmetrical sequences (Whitehead et al., 2001; White and Winans, 2007; 
Antunes et al., 2008). In the present study, we tested the 10 putative CepR binding sites 
described above for the ability to bind purified CepR-OHL complexes. We also 
systematically resected and mutated a known CepR binding site, and use the resulting 
information to identify four new promoters that are regulated directly by CepR. All four 
promoters are regulated by CepR in vivo, require their binding sites for regulation, and 
bind with high affinity to CepR-OHL in vitro. 
 
2.3 Results	   
 
 Note that only partial results correlating to the work in which I contributed are 
presented below. 
2.3.1. Binding of CepR to 10 known or putative CepR binding sites 
 As described above, another group identified 10 putative CepR binding sites that 
lay upstream of CepR-regulated promoters (Chambers et al., 2006). However, these DNA 
sequences were not tested for CepR binding, and were not shown to be required for 
CepR-dependent gene expression in vivo. As CepR-OHL complexes have been shown to 
bind DNA fragments in electrophoretic mobility shift assays (EMSA) and DNase 
footprinting (Weingart et al., 2005), I therefore assayed CepR binding to these 10 
sequences. The 10 sites include the two that we had previously tested, one in the cepI 
promoter and the other in the aidA promoter. Synthetic double-stranded oligonucleotides 
38 base pairs long were radiolabelled, combined with purified CepR-OHL complexes in 
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the presence of a 10 000-fold excess (mass/mass) of calf thymus DNA, and size 
fractionated using native gel electrophoresis. CepR bound to the 38-mer containing the 
cepI binding site with an affinity of approximately 65 nM, in reasonable agreement with 
previous estimates (Fig. 2.1). It also bound to the fragment containing the aidA cep box, 
although significantly more weakly, also as expected (Weingart et al., 2005). To our 
surprise, of the eight other DNA fragments tested, only one was detectably shifted, even 
using very high concentrations of CepR (Fig. 2.1). The shifted fragment was that of the 
phuR promoter, which appeared to form two shifted complexes. I also tested the 
consensus sequence that was derived in the Chambers study (Chambers et al., 2006). 
Because this consensus was only 18 nucleotides in length, we used flanking sequences 
that were derived from the cepI cep box. This consensus sequence was bound by CepR 
with relatively high affinity (Kd = 210 nM, Fig. 2.1).  
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Fig. 2.1. Electrophoretic mobility shift assays of putative CepR binding sites. Synthetic double-
stranded DNA fragments 38 nucleotides long were end-labelled, combined with purified CepR-
OHL complexes, and size-fractionated using native PAGE. In panel 1 and 11, CepR-OHL was 
added at the following concentrations (lanes 1–5): 0 nM, 21 nM, 65 nM, 210 nM and 650 nM. In 
all other panels, CepR-OHL was added at the following concentrations (lane 1–5): 0 nM, 650 nM, 
2060 nM, 6500 nM and 20 600 nM. Free DNA is indicated with a filled triangle and shifted 
complexes are indicated using an arrow. Work done by Ryan. 
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2.3.2. Contribution of each base to binding affinity in vitro 
 As a working hypothesis, it was assumed that the CepR DNA binding domain 
probably has twofold rotational symmetry and that the DNA binding sites should 
therefore have dyad symmetry. Identifying a fully symmetric binding site would greatly 
facilitate mutagenesis studies, as we could then construct duplex DNA molecules each 
containing two copies of the same oligonucleotide. We therefore set out to identify a 
high-affinity CepR binding site that was perfectly symmetric. 
 This work was conducted by Dr. Esther Costa, who constructed two DNA 
fragments, designated L-L′ and R′-R, which are fully symmetrical, and designed using 
the left half and right half of the wild-type cep box of the cepI promoter respectively (Fig. 
2.2). Fragment L-L′ bound CepR with threefold higher affinity than the wild-type 
sequence, and appeared to form well-focused complexes rather than smears. This finding 
provides further evidence that CepR binds DNA as a rotationally symmetric dimer. In 
contrast, fragment R′-R bound CepR weakly. This indicates that sequences within the left 
(promoter-distal) half-site of the wild-type cep box contribute more to the overall binding 
affinity than do the sequences within the right (promoter-proximal) half-site. Fragment L-
L′ was there- fore used as a starting point for systematic mutagenesis. 
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Fig. 2.2. CepR binding affinity for fully symmetrical CepR binding sites. The sequence 
designated L-L′ is composed of sequences of the native cep box of the cepI promoter from 
positions -11 to -1 followed by the inverse complement of these sequences. Fragment R′-R is 
similar but contains sequences of the native cep box from positions +1 to +11, and their inverse 
complements at positions -11 to -1. DNA fragments were radiolabelled and combined with CepR-
OHL in the following concentrations (lanes 1–10) 0 nM, 0.6 nM, 1.8 nM, 6 nM, 18 nM, 60 nM, 
180 nM, 580 nM, 1830 nM and 5780 nM. Complexes were size-fractionated by native PAGE. Kd 
values were calculated by determining the amount of CepR-OHL required to shift half of the 
DNA fragments. Word was done by Costa. 
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Fig. 2.3. Summary of binding affinities of cep boxes having the indicated alterations. Only the 
left half-site is shown. Wild-type binding affinity is indicated using a dashed horizontal line. 
A. Affinity of wild type and mutant cep boxes for CepR-OHL. Work done by Wei. B. Affinity 
of wild type and mutant tra boxes for TraR of A. tumefaciens is shown for comparison (White 
and Winans, 2007). 
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2.3.3. CepR causes a DNA bend at its binding site 
 As described above, the critical bases required for CepR binding extend from 
nucleotide -9 to -5 (and +5 to +9 on the opposite half-site, see Fig. 2.3A). This is in some 
ways quite different from the sequences decoded by TraR of A. tumefaciens (White and 
Winans, 2007), where nucleotides -6 to -4 (and +4 to +6) were essential (Fig. 2.3B). 
Structural studies showed hydrogen bonding between TraR and these bases (Vannini et 
al., 2002; Zhang et al., 2002). Therefore, the critical bases detected by CepR are located 
considerably further from the dyad axis than those bases detected by TraR. Binding each 
of the half-sites of the cep box might require that the DNA recognition helices of CepR 
be further apart from each other than their counterparts in TraR. Alternatively or 
additionally, CepR might impart a higher angle DNA bend to a cep box than does TraR 
to a tra box, in effect bringing the two half-sites of DNA closer together. TraR induces a 
30° bend in this DNA sequence (Vannini et al., 2002; Zhang et al., 2002; Pappas and 
Winans, 2003), and this model predicts that CepR might impart a greater bend. 
 To determine whether CepR causes a DNA bend at its binding site, I introduced a 
DNA sequence containing a consensus cep box into plasmid pBEND3, a plasmid that 
facilitates the study of intrinsic or protein-induced DNA bending (Zwieb and Brown, 
1990). This plasmid allows the creation of a set of DNA fragments that are the same 
length and circularly permuted (Fig. 2.4.C). The cep box will therefore lie near one end 
of some fragments and closer to the center of other fragments. If CepR causes a DNA 
bend, then complexes having this bend near the center of the fragment will migrate in 
electrophoretic gels more slowly than complexes whose bend is closer to one end of the 
fragment (Zwieb and Brown, 1990). The resulting plasmid was digested individually with 
three different restriction endonucleases, added sufficient CepR to shift these fragments 
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and size-fractionated these complexes by native PAGE (Fig. 2.4). For comparison, a 
similar analysis was done using the TraR binding site and purified TraR.  
 The mobility of the EcoRV-generated fragment was considerably lower than 
fragments generated by the other two enzymes (Fig. 2.4A). This is diagnostic of a DNA 
bend. An identical analysis using TraR and tra box DNA showed a somewhat similar 
result (Fig. 2.4B). However, the differences in mobility were less pronounced, indicating 
a lower angle DNA bend. Using the equation of Thompson and Landy (Thompson and 
Landy, 1988), I estimate the bend angle to be approximately 45° for CepR and 30° for 
TraR. Structural studies of TraR-DNA complexes agree with this estimate (Vannini et al., 
2002; Zhang et al., 2002). These data indicate that CepR causes a higher angle DNA 
bend than does TraR, confirming our predictions. 
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Fig. 2.4. Assays for a CepR-directed DNA bend. A. The optimal CepR binding site, as 
determined in Fig. 5 (ACCCTGTCAGATCTCACAGGGT) was introduced into plasmid 
pBEND3, and the resulting plasmid was digested individually with restriction 
endonucleases BamHI (lane 1, 2), EcoRV (lane 3) or MluI (lane 4), combined with 
CepR-OHL (lanes 2–4), and size-fractionated by native PAGE. B. A similar plasmid was 
constructed containing the consensus tra box, cut with BamHI (lane 5, 6) EcoRV (lane 7) 
or MluI (lane 8). Fragments were combined with TraR-OOHL (lanes 6–8), and size-
fractionated by native PAGE. C. A map of the multiple cloning site of the pBEND3 
derivatives containing a cep box or a tra box. Work done by Ryan. 
 
 
2.3.4. Identification of new CepR-regulated promoters 
 The enoLOGOS web server (Workman et al., 2005) was used to obtain a pictorial 
representation of the most favored bases in a canonical cep box. The dissociation 
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constants were used as input, and the few mutant sequences that were not detectably 
bound by CepR were arbitrarily assigned a dissociation constant of 1 mM, which is 
eightfold weaker than the weakest detected binding. The resulting cep box logo is shown 
in Fig. 2.5. The EnoLOGOS web server also converted these dissociation constants into a 
log-likelihood matrix. This matrix was used to obtain a similarity score between the cep 
box logo and every 22 nucleotide sequence in the B. cenocepacia genome. This was done 
by Dr. David Schneider (USDA) using the MOODS algorithm (Korhonen et al., 2009), 
which provided a list of 237 possible cep boxes and scored their similarity to the 
consensus sequence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.5. A cep box logo, derived from the experimental dissociation constants 
for mutant cep boxes and enoLOGOS. 
 
 Many of the DNA sequences that resemble the cep box logo lie far from any 
predicted promoter. However, 142 of these sites lie within 300 nucleotides upstream of a 
predicted translation start site. The expression of most of these genes is not affected by a 
CepR mutation (O’Grady et al., 2009). However, 43 genes that have possible nearby cep 
boxes are differentially expressed at least twofold by a mutation in cepR. Of these 43 
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genes, 13 were chosen for further analysis (Table 2.1). These 13 were chosen for a 
variety of reasons. Two were cepI and aidA, which served as positive controls. We also 
chose the cepR promoter, which was said to be autorepressed in one study (Lewenza and 
Sokol, 2001) but not in another (O’Grady et al., 2009). BCAM0188 encodes CepR2, 
which if induced would show a quorum cascade. Two other genes are adjacent to 
BCAM0188. BCAM1869 was chosen because it lies adjacent to and divergent from 
cepR. BCAM1413a and BCAM1414 were chosen because they encode three AidA 
homologues. The promoter of pBCA055 was found to be induced in an earlier study from 
our lab (Weingart et al., 2005). 
 To determine whether these genes were indeed regulated by CepR, Dr. Flores-
Mireles fused each of the 13 putative promoters to lacZ on a multicopy plasmid. Each 
fragment extended upstream just far enough to include the putative CepR binding site 
plus 6–8 extra nucleotides. Thirteen similar fragments were constructed that included 
only the downstream half of the predicted binding sites. All 26 plasmids were introduced 
into the cepI mutant strain K56-2I and tested for induction of β-galactosidase in the 
absence of OHL or in the presence of two OHL concentrations, one that causes 
approximately half-maximal induction of cepI and aidA (Weingart et al., 2005), and one 
that causes maximal expression. 
 Of the 13 plasmids containing full CepR binding sites, 12 were predicted to be 
induced by OHL, as one (cepR) was predicted to be repressed. Of these twelve, seven 
were induced at least fourfold by 1 mM OHL (Table 2.1). Of these seven, induction of 
six was abolished or severely reduced in isogenic plasmids containing only half of the 
putative cep box (Table 2.1). The exception was the BCAM0186 promoter, which was 
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strongly induced even with only half of its cep box. This gene lies close to BCAM0188 
(cepR2), and may be regulated by the CepR2 protein (Malott et al., 2009). Of the six 
promoters whose OHL induction required a cep box, two were previously characterized 
(cepI and aidA), while four were new [BCAL0510, BCAM1869, BCAS0156 and 
pBCA055-4 (bqiCD)]. Three of these four genes were previously shown to be induced by 
CepR, and to be unaffected by mutations in CciR or CepR2 (Malott et al., 2009; O’Grady 
et al., 2009), although those studies did not show whether CepR acted directly or 
indirectly. The fourth is BCAS0156, which was not previously reported to be induced. 
 The four newly identified CepR-regulated promoters are divided among the four 
replicons. BCAL0510 lies on the largest chromosome and its product resembles a group 
of hypothetical proteins (data not shown). BCAM1869, lies on chromosome 2 and is 
adjacent to and divergent from cepR. The cep box lies 114 nucleotide upstream of the 
BCAM1869 translation start site. Induction was reduced, although not abolished, by 
removing the promoter-distal half of the cep box. BCAM1869 and cepR are adjacent in 
many species of Burkholderia, providing suggestive evidence that their proteins are in 
some way functionally linked. A protein homologous to BCAM1869 was recently shown 
to play a role in transcription regulation (Mattiuzzo et al., 2010). The cepR gene was 
previously identified as being autorepressed in one study (Lewenza and Sokol, 2001), 
although in another study it was found to be unregulated by CepR (O’Grady et al., 2009). 
Our data support the latter study (Table 2.1). BCAS0156, which lies on chromosome 3, 
resembles a family of b-lactamases and other penicillin-binding proteins (pfam00144). 
pBCA055 (bqiC) and pBCA054 (bqiD) lie on the 93 KB plasmid and appear to be 
expressed as an operon. pBCA055 is a multidomain protein whose central domain 
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resembles GGDEF proteins (COG2199) and whose C-terminal domain resembles EAL 
proteins (pfam00563), and may therefore synthesize and or degrade c-di-GMP (Romling 
and Amikam, 2006). pBCA054 has a C-terminal domain that resembles the DNA binding 
domains of LuxR proteins (pfam00196), suggesting that it may be a transcription factor. 
 The fact that these six promoters required OHL and a putative CepR binding site 
for induction suggested that CepR might directly activate them. To provide additional 
evidence, I determined whether CepR and OHL could activate these promoters in a 
heterologous host lacking any other LuxR-type protein. I introduced into E. coli strain 
MC4100 plasmids containing each of the six inducible promoters as well as plasmids 
containing the same promoters but containing only part of the CepR binding site. These 
strains also contained a second plasmid expressing CepR or a vector control. Strains 
containing CepR were cultured in the presence or absence of OHL and assayed for β-
galactosidase. All six strains containing CepR and a full cep box showed strong induction 
of β-galactosidase by OHL (Table 2.2). Strains whose plasmids lacked the full cep boxes 
were either uninduced or weakly induced by OHL, as expected. Strains lacking CepR 
were not induced by OHL, also as expected. I conclude that for each promoter, induction 
by OHL requires CepR and a CepR binding site. The reconstitution of CepR-dependent 
induction of these promoters in E. coli provides further evidence that each is directly 
regulated by CepR. 
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Table 2.1 Induction of B. cenocepacia genes by OHL. Work done by Flores-Mireles. 
Gene Sequence Score cep box No OHL 
OHL 
(1nM) Ratio 
OHL 
(1uM) Ratio 
BCAL0510 CGCCCGCCAGAATTGACAGGCC 6.338 full 38 ± 2 469 ± 117 3.5 747 ± 73 5.4 
half 351 ± 27 167 ± 40 0.5 303 ± 16 0.9 
BCAM0186  ACCCTGTGATTTGATGCCGGTC 9.398 
full  43 ± 7 97 ± 6 2.3 77 ± 67 17.9 
half 63 ± 6 69 ± 3 1.1 762 ± 34 12.1 
BCAM0188 
(cepR2) ATCCTGTTCAAAAGGACAGTTT -­‐1.875	  
full  543 ± 134   743 ± 141 1.4 145  ± 105 2.6 
half 669 ± 23 876 ± 27 1.3 1678 ± 223 2.5 
BCAM0189 
(cnaR) ATCCTGTTCAAAAGGACAGTTT -­‐1.875	  
full 180 ± 17  150 ± 17 0.8 360 ± 16 2 
half 170 ± 5 123 ± 9 0.7 329 ± 40 1.9 
BCAM1413
a (aidC) TACCTGTCAGGTTTGATGGGGG 6.26 
full 134 ± 6 145 ± 6 1.1 408 ± 26 3.1 
half   173 ± 16 201 ± 8 1.1  217 ±  29 1.2 
BCAM1414 TACCTGTCAGGTTTGATGGGGG 6.26 
full     80 ± 23  83 ± 8 1.03 175 ± 52 2.1 
half 101 ± 8  93 ± 9 0.9 114 ± 10 1.1 
BCAM1868 
(cepR) ACGCTGTCATACTTGTCAGGTT -­‐8.188	  
full  205 ± 6 193 ± 4 0.94 224 ± 16 1.1 
half nd nd nd nd nd 
BCAM186 ACGCTGTCATACTTGTCAGGTT -­‐8.188	  
full   179 ± 13 1598 ± 193 8.9 3536 ± 125 19.7 
half   121 ± 12 153 ± 3 1.3 609 ± 45 5 
BCAM1870 
(cepI) ACCCTGTAAGAGTTACCAGTTA -­‐5.885	  
full   60 ± 3  655 ± 25 10.9 2489 ± 162 41.5 
half    40 ± 16  39 ± 3 0.9 133 ± 42 3.3 
BCAS0155-
0153 ATACTGTTAAAACCGGCAGGTT -­‐9.521	  
full   67 ± 4  72 ± 6 1.1 176 ± 44 2.6 
Half    87 ± 7  61 ± 4 0.7 114 ± 10 1.3 
BCAS0156 ATACTGTTAAAACCGGCAGGTT -­‐9.521	  
full   110 ± 22  518 ± 64 4.7 1399 ± 144 12.7 
half 101 ± 7  84 ± 6 0.8 116 ± 14 1.1 
BCAS0293 
(aidA) AAGCTGTAAAAGTAAACAGGTC -­‐1.315	  
full 109 ± 9  416 ± 18 3.8 1648 ± 61 15.1 
half 118 ± 8 108 ± 7 0.9  174 ± 32 1.6 
pBCA055-0
54 (bqiCD) CCACTGTCAAATCTACGAGGGC 2.799 
full   149 ± 49    775 ± 193 5.2    3126 ± 1052 20.9 
half 167 ± 6 167 ± 1 1   272 ± 106 1.6 
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Table 2.2 Activation of CepR-regulated promoters in the heterologous host E. coli. 
Work done by Ryan. 
Gene	   cep	  box	  
+	  CepR	  
Ratio	  
-­‐	  CepR	  
Ratio	  
No	  OHL	   (1	  μM)	   (1	  μM)	  
BCAM1870	  
(cepI)	  
full	   4	  ±	  0.2	   491	  ±	  6.2	   128	   4	  ±	  0.7	   120	  
half	   4	  ±	  0.2	   12	  ±	  2.7	   3	   4	  ±	  1.1	   3	  
BCAS0293	  
(aidA)	  
full	   4	  ±	  0.2	   176	  ±	  17.7	   44	   4	  ±	  0.7	   43	  
half	   4	  ±	  0.1	   8	  ±	  1	   2	   3	  ±	  0.3	   3	  
BCAL0510	  
full	   4	  ±	  0.1	   49	  ±	  3.3	   13	   4	  ±	  0	   14	  
half	   4	  ±	  0.1	   11	  ±	  0.4	   3	   5	  ±	  0.9	   2	  
BCAM1869	  
(cepJ)	  
full	   3	  ±	  0.1	   211	  ±	  6.9	   65	   4	  ±	  0.3	   52	  
half	   4	  ±	  0.2	   29	  ±	  0.7	   7	   4	  ±	  0.1	   8	  
pBCA055-­‐
054	  (bqiCD)	  
full	   4	  ±	  0.1	   159	  ±	  13.4	   44	   3	  ±	  0.2	   48	  
half	   4	  ±	  0.1	   4	  ±	  0.5	   1	   3	  ±	  0	   1	  
BCAS0156	  
full	   4	  ±	  0.2	   41	  ±	  1.3	   10	   3	  ±	  0.4	   12	  
half	   4	  ±	  0.1	   3	  ±	  0.1	   1	   3	  ±	  0.2	   1	  
pYWN302.1	   	   4	  ±	  0.3	   3	  ±	  0.1	   1	   4	  ±	  0.2	   1	  
 
 
 
I used EMSA to test whether purified CepR could bind these sites in vitro. Synthetic 
duplex oligonucleotides 26 base pairs in length were combined with highly purified 
CepR-OHL complexes and size-fractionated by native PAGE (Fig. 2.6). All of the six 
inducible promoters were shifted, indicating that they can be bound by CepR. These data 
are therefore consistent with the hypothesis that these four genes are directly regulated by 
CepR-OHL complexes. 
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Fig. 2.6. CepR binding affinity for all known cep boxes. Duplex DNA molecules 26 
nucleotides in length containing the sequences shown in Fig. 10 were radiolabelled, 
combined with purified CepR-OHL, and the resulting complexes were size-
fractionated by native PAGE. For the cepI cep box (upper left panel), CepR-OHL 
was added at the following concentrations (lanes 1–5): 0 nM, 
21 nM, 65 nM, 210 nM and 650 nM. In all other panels, CepR-OHL was added at 
the following concentrations (lane 1–5): 0 nM, 650 nM, 2060 nM, 6500 nM and 20 
600 nM. Work done by Ryan. 
 
 
 
2.4 Discussion 
 
 Members of our laboratory have previously used genetic, biochemical and 
structural approaches to study interactions between another LuxR-type protein, TraR, and 
its DNA binding site. TraR binds DNA as a dimer, and the two DNA binding domains of 
each dimer have twofold rotational symmetry. The DNA binding site also has twofold 
rotational symmetry, and complexes between the TraR-CTD and DNA also have 
	   49	  
rotational symmetry. This type of symmetry is found in the binding sites of other LuxR-
type proteins, and of a great number of other DNA binding proteins. The imperfect dyad 
symmetry of two CepR binding sites leads us to believe that CepR would follow a similar 
pattern. It was therefore interesting that the consensus sequence previously described had 
several highly conserved asymmetric bases (Chambers et al., 2006). Unfortunately, only 
three of the ten putative bindings sites was detectably bound by purified CepR-OHL. Our 
studies suggest that a core CTG-N10-CAG is critical for binding. Loss of one of these six 
bases may be tolerated, but loss of any two or more probably is not. Of the 10 DNA 
sequences compiled in the Chambers study, three had all six bases of this consensus and 
were bound by CepR-OHL, while seven sequences lacked between one and four of these 
bases, and were not bound. The consensus sequence identified previously (Chambers et 
al., 2006) also has all six of these bases, and was bound. In the Chambers study, there 
seemed to be an implicit assumption that all CepR-inducible genes would be induced 
directly by CepR. In light of the present data, it seems more likely that induction of some 
genes could occur indirectly. 
 In order to study specifically how CepR decodes its binding site, we felt it was 
important to move to an in vitro system using purified components. The finding that 26 
nucleotides are needed for full binding affinity was somewhat surprising, as this sequence 
would extend 2.5 helical turns, or 1.25 turns per half-site. It is far from clear why such a 
long sequence would be required. CepR does not strongly discriminate specific sequences 
at positions -11, -10,+10 or +11 (Fig. 2.3), suggesting that the need for bases far removed 
from the dyad center may not be sequence-specific.  
 We also tested a set of 22 nucleotide, perfectly symmetric sequences based upon 
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the left half-site of the cepI cep box. Mutation of any of the bases from -9 to -5 (and the 
corresponding bases at +5 to +9) either abolished or strongly impaired binding affinity. 
From these data, we conclude that the core CepR binding site could be amended from the 
16 nucleotide sequence CTG-N10-CAG to the 18 nucleotide sequence CCTGT-N8-
ACAGG. We had previously discounted the bases at positions -9, -5, +5 and +9 as they 
are not part of the dyad symmetry of the two cep boxes previously aligned (Weingart et 
al., 2005). However, these bases are somewhat conserved in a new set of CepR binding 
sites. 
 The effects of mutations within the central spacer (-4 to +4) had more variable 
effects on binding affinity. Mutations from A to C or T at position -4 (and from T to G or 
A at position +4) enhanced affinity, indicating that the original L-L′ sequence was not 
optimal at this position. Many of the newly identified cep boxes contain the bases C or T 
at position -4 and a G or A at position +4. We denote the cep box residues from -4 to +4 
as the central spacer, and predict that there are no sequence-specific protein–DNA 
contacts in this region, as was shown for TraR (Vannini et al., 2002; Zhang et al., 2002). 
It is well established that non-contacted bases can have large effects on protein affinity, 
generally via effects on the helical pitch or on the flexibility of the DNA, or by imparting 
a sequence-directed DNA bend (Sarai and Kono, 2005). This phenomenon is sometimes 
referred to as “indirect readout”, while sequence decoding by direct protein-DNA 
interactions is called “direct readout”. 
 The identification of the bases essential for CepR binding facilitated a search for 
new genes that could be regulated directly by CepR. Of the thirteen promoters that were 
tested, six were significantly induced by OHL and required the putative cep box for this 
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induction. These six CepR-regulated genes are distributed across all three chromosomes 
and the 92 KB plasmid. BCAS0293 (aidA) was reported previously to be OHL- regulated 
(Aguilar et al., 2003a; Riedel et al., 2003; Weingart et al., 2005; Chambers et al., 2006). 
This gene is in a two-gene operon, and the downstream gene, aidB, is homologous to 
aidA. This homology extends to three additional genes that we designate aidC, aidD and 
aidE (BCAM1413a, BCAM1412, and BCAM1414, respectively, see Fig. S3), none of 
which was induced more than 2–3 fold by OHL (Table 2.1). BCAM1413a and 
BCAM1414 are divergent and flank a cep box, although the score of this site is weak 
(Table 2.1). The roles of these proteins are unknown, although AidA was previously 
reported to play a role in the slow killing of the nematode Caenorhabditis elegans (Huber 
et al., 2004). All five proteins are members of the PixA protein family (pfam12306). 
 In this study, we also examined the regulation of gene BCAM0186. This gene was 
unusual in that it was strongly induced by OHL and had a possible cep box, yet induction 
was cep box-independent. In hindsight, this should not have been surprising, as the 
similarity between this putative cep box and the consensus is rather weak, and the cep 
box lies almost 600 nucleotides upstream of the BCAM0186 translation start site. Its 
expression was reported to be inhibited by the product of the nearby BCAM0188 (cepR2) 
(Malott et al., 2009). We hypothesize that BCAM0186 may be directly repressed by 
CepR2, and that repression might be blocked by OHL. 
 
2.5 Experimental procedures 
 
 Note that only the procedures for the experiments I performed are included below. 
For the complete experimental procudures for this study, see the published manuscript1. 
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Bacterial strains and growth conditions 
  
 Strains used in this study are described in Table 2.3. As needed, B. cenocepacia 
was cultured in 100 µg ml-1 of trimethoprim or 300 µg ml-1 of tetracycline. E. coli strains 
were cultured with 15 µg ml-1 of tetracycline, 100 µg ml-1 of streptomycin or 100 µg ml-1 
of ampicillin. Plasmid pYWN302 was constructed by digesting pKP302 (Pappas and 
Winans, 2003) with NsiI, and inserting an NsiI fragment containing the tet gene of 
pBBR-MCS3.  
Measurement of DNA bending by CepR 
 
 Synthetic oligonucleotides containing a consensus cep box or tra box are described 
in Table 2.4. They were allowed to self-anneal by heating to 95°C for 5 min and then 
gradually cooled to room temperature, then digested simultaneously with XbaI and SalI, 
and introduced into plasmid pBEND3 (Zwieb and Brown, 1990) after digestion with the 
same enzymes. The resulting plasmids, pGR110 (containing a cep box) and pGR111 
(containing a tra box), were digested individually with BamHI, EcoRV or MluI to 
permute the position of the box with respect to the DNA termini, radiolabelled using T4 
polynucleotide kinase (New England Biolabs) and [gamma-P32]-ATP and purified using 
Centri-Spin columns (Princeton Separations). Binding reactions (10 ml) contained 800 ng 
DNA and clarified lysates containing overexpressed CepR-OHL or TraR-OOHL in a 
buffer containing 10 mM Tris- HCl (pH 7.9), 1 mM EDTA, 1 mM DTT, 60 mM 
potassium glutamate, 30 mg ml-1  calf thymus DNA, 20 mg ml-1  BSA, and 10% glycerol, 
and were incubated for 30 min at 4°C, size-fractionated using a 14% polyacrylamide gel 
in TAE buffer. 
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Identification of new CepR-regulated promoters 
 
 The enoLOGOS (Workman et al., 2005) web server was used to construct a log-
likelihood matrix from a set of EMSA- derived Kd values for set of 22 nucleotide 
sequences shown in Fig. 6. The Kd value for the reference sequence and each of its 
variants were converted to association constants which were entered into the program. 
EnoLOGOS returned a log-likelihood matrix, calibrated for a GC content of 67%, and 
scaled by a factor of -1 to conform to the usual sign convention for binding energies. 
DNA sequences that resemble the cep box logo were identified using the log-likelihood 
matrix and the MOODS algorithm (Korhonen et al., 2009). This algorithm created a set 
of over eight million 22 nucleotide sequences derived from the B. cenocepacia genome, 
each overlapping its nearest neighbors by 21 nucleotides. Each of these sequences was 
compared with the canonical cep box using the log-likelihood matrix. The optimal and 
least optimal sequences received scores of approximately -39 and 160, respectively, 
while the two confirmed CepR binding sites, upstream of the cepI and aidA promoters, 
received scores of -5.9, and -1.3 respectively. 
 Promoters containing suspected CepR binding sites were PCR amplified using 
oligonucleotides shown in Table 2.4. For each promoter, a fragment containing a 
complete CepR binding site was amplified, as well as a similar fragment containing only 
the promoter-proximal half of the site. These PCR fragments contained a KpnI site at the 
promoter-distal end, and a PstI site at the promoter-proximal end. The PCR fragments 
were purified by using QIAquick Gel Extraction Kits (Qiagen) and digested with KpnI 
and PstI (New England Biolabs). The digested fragments were cloned into the promoter 
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probe plasmid pYWN302, generating transcriptional fusions between each promoter and 
lacZ. The resulting plasmids were introduced into B. cenocepacia strain K56-I2 or E. coli 
strain MC4100 by electroporation. For assays of β-galactosidase, B. cenocepacia and E. 
coli strains were cultured in LB medium supplemented with either 300 mg of tetracycline 
or 100 ug ml-1 kanamycin and 12 ug ml-1tetracycline, respectively, overnight at 37°C. 
Each culture was diluted 1:100 into LB medium containing the indicated concentrations 
of OHL, and incubated with aeration at 37°C to an OD600 of 0.4, and assayed for β-
galactosidase specific activity (Miller, 1972). Experiments were performed in triplicate 
with three different isolates of each strain. 
 
Table 2.3 Strains used in this study 
Strains and 
Plasmids 
Relevant features Reference 
Strains   
K56-2 B. cenocepacia wild type 
Lewenza et 
al. 1999 
K56-I2 B. cenocepacia K56 cepI::TpR Lewenza et al. 1999 
DH5α E. coli α-complementation Stratagene 
MC4100 F- araD139 Δ(argF-lac)U169 rpsL150 relA1 deoC1 rbsR fthD5301 fruA25 λ- 
Ferenci et 
al., 2009 
Plasmids   
pBEND3 plasmid to facilitate measuring bent DNA Zwieb et al., 1990 
pYW302 Derivative of pKP302 expressing TcR This study 
pGR110 pBEND3 containing cep box, using GR151, GR152 This study 
pGR111 pBEND3 containing tra box, using GR157, GR158 This study 
pCW106 pRSETA derivative containing cepR Weingart et al., 2005 
pSRKKm Broad host range expression vector, KmR Khan et al., 2008 
pAFM113 pSRKKm derivative containing cepR  This study 
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pAFM323  BCAM1870 (cepI) full cep box cloned into pYWN302-1  This study  
pAFM318  BCAM1870 (cepI) half cep box cloned into pYWN302-1  This study  
pAFM266  BCAM1413a (aidC) full cep box cloned into pYWN302-1  This study  
pAFM267  BCAM1413a (aidC) half cep box cloned into pYWN302-1  This study  
pAFM263  BCAL510 full cep box cloned into pYWN302-1  This study  
pAFM264  BCAL510 half cep box cloned into pYWN302-1  This study  
pAFM271  BCAM1869 (cepJ) full cep box cloned into pYWN302-1  This study  
pAFM272  BCAM1869 (cepJ) half cep box cloned into pYWN302-1  This study  
pAFM314  BCAM0156 full cep box cloned into pYWN302-1  This study  
pAFM315  BCAM0156 half cep box cloned into pYWN302-1  This study  
 
 
Table 2.4.  Oligonucleotides used in this study 
Primers for cloning cep and tra box permutated variants 
 
GR151 GCTTCTAGAACCCTGTAAGAGTTACCAGT cep box forward, pairs with GR152 
GR152 GCTGTCGACTGTAACTGGTAACTCTTACA cep box reverse, pairs with GR151 
GR157 CTAGACCGTATGTGCAGATCTGCACATGA tra box forward, pairs with GR158 
GR158 TCGACAATCATGTGCAGATCTGCACATAC tra box reverse, pairs with GR157 
Oligonucleotides for EMSA hybridization duplexes of cep boxes identified by Wei et al., 
2011 
GR159 ACTCGATTGATTCCGATTTTAA BCAS0293 (aidA) forward 
GR160 TGCGGAGGCGACGGCTAA BCAS0293 (aidA) reverse 
GR161 GGTTTATCGCGACTTTTGC BCAL0510  forward 
GR162 GCCTCGGATGGCACAA BCAL0510 reverse 
GR165 TGGTAGGCATCCTGCCAG BCAM1869 forward 
GR166 AAGGGTGAAGTCATGCG BCAM1869 reverse 
GR167 TCTTTTTCATCGATTTTCGACG BCAS0156 forward 
GR168 AACGAGGCCGCCGTCAT BCAS0156 reverse 
GR169 TGATCAAGAAACCGTTACCACGT BCAM1870 forward 
GR170 CTGTGCTTTTGTATGCGTGCATT BCAM1870 reverse 
GR171 GAACGAGGCCGCCGTCAT BCAS0155 forward 
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GR172 TCTTTTTCATCGATTTTCGACGC BCAS0155 reverse 
GR173 ACTGCGACAATTGGTCTTCTAT pBCA055-4 (BqiC) forward 
GR174 ACGAGATGTTTCTTCGGAAAGGA pBCA055-4 (BqiC) reverse 
GR265 CGCCGTCACCCTGTAAGAGTTACC BCAM1870 (cepI) gel shift forward 
Oligonucleotides for EMSA hybridization duplexes of cep boxes identified by Wei et al., 
2011 
GR266 CTCATTTACACTGTTAAAGTTGTC BCAM2626 (phuR) forward 
GR267 AACATCAAAATTGACAAAGTTATC BCAM077 forward 
GR268 ATCATGGAAGCTGTAAAAGTAAAC BCAS0293 (aidA) forward 
GR269 TATTACCTTTCGGCAATAGTTGCC BCAL1354 forward 
GR270 GACACGTCTTGTTTAAAAGTCATC BCAS0409 (zmpA) forward 
GR271 GTCGTGCAACCAGTAAAACTTGCG BCALL0340 forward 
GR272 GGATTCCGTTCGCTTAGAGTTGTT BCAM0009 forward 
GR273 ATCCAGTGTCAAGTCAGACTTGAC BCAL0715 forward 
GR274 TCGTCGATGGTTGAAAGTGTCATC BCAL3191 (caiA) forward 
GR275 CGCCGTCACCCTGTAAAAGTTACC Consensus (cep box) forward 
GR276 AGGAGCCTGTAACTGGTAACTCTT BCAM1870 (cepI) reverse 
GR277 TGTGAAAGGCAACTGACAACTTTA BCAM2626 (phuR) reverse 
GR278 TTAAAGTCATAACTGATAACTTTG BCAM077 reverse 
GR279 CATTTTCCCGACCTGTTTACTTTT BCAS0293 (aidA) reverse 
GR280 GCTCAATCGAAACAGGCAACTATT BCAL1354 reverse 
GR281 GGAATGCATCAAGTGATGACTTTT BCAS0409 (zmpA) reverse 
GR282 TTTCGACCGGAATGCGCAAGTTTT BCALL0340 reverse 
GR283 AATTCGAAATATCGAACAACTCTA BCAM0009 reverse 
GR284 CGCCTTTACAAGCTGTCAAGTCTG BCAL0715 reverse 
GR285 CCAGTGTAGCACCGGATGACACTT BCAL3191 (caiA) reverse 
GR286 AGGAGCCTGTAACTGGTAACTTTT Consensus (cep box) reverse 
Oligonucleotides for cloning cep box fusions 
   
ALFM323-Y  GGGGTACCCACCCTGTAAGAGTTACCAG BCAM1870 (cepI) full cep box fusion, pairs with ALFM319-Y  
ALFM318-Y  GGGGTACCTTACCAGTTACAGGCTCCTCG BCAM1870 (cepI) half cep box fusion, pairs with ALFM319-Y  
ALFM319-Y  AACTGCAGTTTCGCGCGAACACGTAGA  
BCAM1870 (cepI) cep box fusion 
pairs with ALFM318-Y and 
ALFM323-Y  
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ALFM320-Y  GGGGTACCCCGACCTGTTTACTTTTACAG BCAS0293 (aidA) full cep box fusion pairs with ALFM321-Y  
ALFM321-Y  GGGGTACCCTTTTACAGCTTCCATGACC  BCAS0293 (aidA) half cep box fusion pairs with ALFM321-Y  
ALFM322-Y  AACTGCAGGTCGCCGACCTGCGCCTTCAG 
BCAS0293 (aidA) cep box fusion 
pairs with ALFM320-Y or 
ALFM321Y  
YWP263  GGGGTACCCTGACGCGGCCTGTCAATTC BCAL0510 full cep box fusion ,pairs with YWP265  
YWP264  GGGGTACCTCTGGCGGGCGCGGCGCGCA BCAL0510 half cep box fusion, pairs with YWP265  
YWP265  AACTGCAGAGCGAGCGGGCAGGAGCGGA  BCAL0510 cep box fusion, pairs with YWP263 or 264  
YWP271  GGGGTACCCAACGTCACGCTGTCATACT BCAM1869 full cep box fusion, pairs with YWP273  
YWP272  GGGGTACCCTTGTCAGGTTTCAGTACCC  BCAM1869 half cep box fusion, pairs with YWP273  
YWP273  AACTGCAGGAGTGCGGCCAGTGCGCCTT  BCAM1869 box fusion, pairs with YWP271 or 272  
ALFM298-Y  GGGGTACCAAAACCTGCCGGTTTTAACAG BCAS0155 full cep box fusion, pairs with ALFM301-Y.  
ALFM299-Y  GGGGTACCTTTTAACAGTATCGAATCCGG  BCAS0155 half cep box fusion, pairs with ALFM301-Y  
ALFM301-Y  AACTGCAGCCGACGCGGCCACGGTTTCG  BCAS0155 box fusion, pairs with ALFM298-Y or ALFM299-Y  
ALFM314-Y  GGGGTACCATACTGTTAAAACCGGCAGT  BCAS0156 box fusion, pairs with ALFM317-Y  
ALFM315-Y  GGGGTACCCCGGCAGGTTTTCCCGGAAA  BCAS0156 half box fusion, pairs with ALFM317-Y  
ALFM317-Y  AACTGCAGGACGATGCCGATCGCCATGCC BCAS0156 box fusion, pairs with ALFM314-Y or ALFM315-Y  
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CHAPTER 3: A LUXR-TYPE REPRESSOR OF Burkholderia cenocepacia 
INHIBITS TARGET PROMOTERS VIA ANTIACTIVATION AND IS 
INHIBITED BY A COGNATE ACYLHOMOSERINE LACTONE 
 
3.1. Summary 
 Burkholderia cenocepacia is an opportunistic human pathogen that encodes two 
LuxI-type acylhomoserine (AHL) synthases and three LuxR-type AHL receptors.  Of 
these, cepI and cepR are tightly linked and form a cognate synthase/receptor pair, as do 
cciI and cciR.  In contrast, CepR2 is unlinked from the other four genes, and lacks a 
genetically linked cognate AHL synthase gene.  Another group showed that a cepR2 
mutant overexpressed a cluster of linked genes that appear to direct the production of a 
secondary metabolite and provided data suggesting that CepR2 did not detect any AHL 
(Malott et al., 2009).  We found that these same genes were upregulated by 
octanoylhomoserine lactone (OHL), which is synthesized by CepI.  Taken together, these 
data suggest that several cepR2-linked promoters were repressed by CepR2 and that 
CepR2 was antagonized by OHL.  Fusions of two divergent promoters to lacZ were used 
to confirm these hypotheses, and promoter resections and DNase I footprinting assays 
revealed a single CepR2 binding site between the two promoters.  Surprisingly, the 
CepR2 binding site lies well upstream of both promoters, suggesting an unusual mode of 
repression.  Adjacent to the cepR2 gene is a gene that we designate cepS, which encodes 
an AraC-type transcription factor.  CepS is essential for expression of both promoters, 
regardless of the CepR2 status or OHL concentration.  CepS therefore acts downstream 
of CepR2, and CepR2 appears to function as a CepS antiactivator. 
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3.2. Introduction 
 
 Although the genus Burkholderia was recognized only 20 years ago (Yabuuchi et 
al., 1992, Anon., 1992), it now encompasses over 50 species (Vanlaere et al., 2009) that 
occupy extremely diverse ecological niches.  Most have rather large genomes and a 
considerable degree of metabolic versatility.  Some species are potentially useful in 
bioremediation of anthropogenic toxic chemicals (Chen et al., 2003).  Other members are 
capable of forming nitrogen-fixing root nodules with legumes and have a full 
complement of nod genes that were formerly thought to be limited to Rhizobium spp. and 
their allies (Bontemps et al., 2010).  Some members protect host plants against fungal 
pathogens (Parke & Gurian-Sherman, 2001).  Other species are pathogenic against plants, 
animals, and humans.  The type strain B. cepacia (originally Pseudomonas cepacia) is a 
pathogen of onions (Burkholder, 1950).  B. mallei causes glanders in equines, while B. 
pseudomallei causes melioidosis in a variety of animals.  Both can also be transmitted to 
humans, and are select agents of concern as possible bioweapons (Godoy et al., 2003).  B. 
mallei was used during World War I in an effort to incapacitate draft animals (Wheelis, 
1998). 
 
Seventeen pathogenic species, including B. mallei, B. pseudomallei, B. 
cenocepacia, B. cepacia, and B. vietnamiensis, are members of the Burkholderia cepacia 
complex, or BCC (Vandamme et al., 1997, Vanlaere et al., 2009, Vanlaere et al., 2008).  
Among these, B. cenocepacia is recognized as an opportunistic pathogen of humans and 
is a particular threat to cystic fibrosis (CF) patients (Mahenthiralingam et al., 2005, 
Vandamme et al., 1997).  Colonization of the CF lung by B. cenocepacia (Vandamme et 
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al., 2003) tends to occur in patients already infected with Pseudomonas aeruginosa, 
another opportunistic pathogen of the CF lung (Jones & Webb, 2003, Vandamme et al., 
1997).  B. cenocepacia strains are resistant to most antibiotics, making them virtually 
impossible to eradicate (Nzula et al., 2002).  Infections with B. cenocepacia may have 
variable clinical outcomes ranging from asymptomatic carriage to a sudden fatal 
deterioration in lung function (Mahenthiralingam et al., 2005).   
 
The genomes of four isolates of B. cenocepacia have been sequenced in their 
entirety while additional genomes are currently being sequenced (NCBI, 2011).  All four 
fully sequenced genomes have three circular chromosomes that vary in size between 3.9 
and 0.88 MB in length, and two have a plasmid.  Chromosome 3 of strain J2315 was 
recently found to be curable (Agnoli et al., 2012), and should therefore be considered a 
plasmid rather than a chromosome. 
 
Many or possibly all Burkholderia spp. encode at least one regulatory system that 
resembles the LuxR and LuxI proteins of Vibrio fischeri, where LuxI synthesizes an 
acylhomoserine lactone (AHL)-type pheromone, also called an autoinducer, and LuxR is 
an AHL-dependent transcriptional regulator (Choi & Greenberg, 1992, Eberhard et al., 
1981, Engebrecht & Silverman, 1984).  Regulatory systems of this family are found in 
countless proteobacteria, where they are thought to allow bacteria to estimate their 
population size and for individual bacteria to coordinate their physiology with their 
siblings.  Collectively, these systems regulate diverse processes, including pathogenesis, 
biofilm formation, bacterial conjugation, and the production of antibiotics and other 
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secondary metabolites (Whitehead et al., 2001).  In general, target genes are transcribed 
preferentially at population densities high enough to favor AHL accumulation (Eberhard 
et al., 1991), a phenomenon sometimes referred to as quorum sensing (Fuqua et al., 
1994).  
 
LuxR-type proteins have two domains, an N-terminal pheromone binding domain 
and a C-terminal DNA binding domain (Pappas et al., 2004).  Purified LuxR, TraR of 
Agrobacterium tumefaciens, LasR of Pseudomonas aeruginosa, and CepR of B. 
cenocepacia, when complexed with their respective AHLs, bind with high specificity to 
recognition sequences (referred to as lux, tra, las, or cep boxes, respectively) that are 
found near target promoters (Schuster et al., 2004, Urbanowski et al., 2004, Zhu & 
Winans, 1999).  LasR is also able to bind to sequences that have no obvious resemblance 
to canonical las boxes (Schuster et al., 2004).   
 
A few members of this family are antagonized by their cognate autoinducers, and 
bind DNA only in their absence (Tsai & Winans, 2010).  Most of these are closely related 
to each other and include EsaR of Pantoea stewartii, ExpR of Pectobacterium 
caratovorum (formerly Erwinia caratovora), and YenR of Yersinia enterocolitica 
(Castang et al., 2006, Cui et al., 2005, Fineran et al., 2005, Minogue et al., 2005, 
Sjoblom et al., 2006, Tsai & Winans, 2011).   At least one LuxR-type protein that is not 
closely related to EsaR, ExpR, or YenR is also antagonized by its cognate AHL.  This is 
the VjbR protein of Brucella melitensis, which functions as an apoprotein to activate 
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expression of a Type IV secretion system, and is inhibited by dodecanoyl-HSL (Delrue et 
al., 2005).    
 
B. cenocepacia J2315 encodes three LuxR homologs and two LuxI homologs 
(Lewenza et al., 1999, Malott et al., 2005, Malott et al., 2009).  Among these, CepR and 
CepI are well conserved within the BCC (Venturi et al., 2004).  CepI synthesizes 
primarily octanoylhomoserine lactone (OHL), and lower levels of hexanoylhomoserine 
lactone (HHL) (Aguilar et al., 2003, Gotschlich et al., 2001, Huber et al., 2001, Lewenza 
et al., 1999).  Null mutations in cepI or cepR increased the production of the siderophore 
ornibactin, and decreased the production of secreted lipases and metalloproteases ZmpA 
and ZmpB (Kooi et al., 2006, Lewenza et al., 1999, Lewenza & Sokol, 2001, Sokol et al., 
2003).  CepI and CepR are also required for swarming motility and biofilm formation 
(Huber et al., 2001) and for pathogenicity in several animal models (Kothe et al., 2003, 
Sokol et al., 2003).  B. cenocepacia J2315 also encodes CciI and CciR, which are found 
on a genomic island called cci (cenocepacia island), that is found only in a subset of B. 
cenocepacia strains (Malott et al., 2005).  The CepIR and CciIR systems extensively 
interact, in that CciR negatively regulates cepI, while CepR is required for expression of 
the cciIR operon (Malott et al., 2005).  Transcriptional profiling studies indicate that 
CepR and CciR regulate many of the same genes, but do so in opposite ways (O'Grady et 
al., 2009).   
 
B. cenocepacia also encodes a third LuxR-type transcription factor, CepR2, 
whose gene is not linked to any apparent AHL synthase gene.  The cepR2 gene was 
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reported to be negatively regulated by the CepR2 protein and by CciR (Malott et al., 
2009).  A cepR2 mutation increased the expression of 64 genes and decreased the 
expression of 127 others (Malott et al., 2009).  These included genes involved in 
virulence, chemotaxis, heat shock, and signal transduction.  Differential expression was 
strongest in a group of genes that are closely linked to cepR2, including cepR2 itself, an 
adjacent gene bcam0189, which encodes an AraC type protein (that we designate CepS), 
a two gene operon (bcam0191-0190), a divergent five-gene operon (bcam0192-0196), 
and a nearby four gene operon (bcam0199-0202).  Bcam0190-0196 are predicted to 
direct the synthesis of a secondary metabolite, while Bcam0199-0202 are predicted to 
direct the efflux of a small molecule.  All of these genes were expressed more strongly in 
the mutant than in wild type, indicating that CepR2 inhibits their expression.  CepR2 was 
fully functional in the absence of any AHL.  In a heterologous system, the ability of 
CepR2 to activate a lux operon was not affected by the addition of any AHL.  It was 
concluded that CepR2 functions independently of AHLs and does not detect them (Malott 
et al., 2009). 
 
Members of our laboratory are interested in the genetic and biochemical 
properties of several LuxR-type proteins, including CepR.  To further those studies, we 
used oligonucleotide microarrays to identify genes that are differentially expressed by 
exogenous OHL, and were surprised to find that several genes that are induced by OHL 
were previously found to be repressed by CepR2 (Malott et al., 2009).  Taking the two 
findings together, this would suggest that OHL antagonizes CepR2 activity, though this 
model was difficult to reconcile with the report that CepR2 was unaffected by any AHL 
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(Malott et al., 2009).  We therefore measured the expression of two CepR2-linked 
promoters in the presence or absence of CepR2 and OHL, both in B. cenocepacia and in 
E. coli, and studied the role of CepS (formerly Bcam0189), a possible regulatory protein, 
in the expression of the same promoters.  We also tested the ability of CepR2 to bind 
OHL in vivo and to fold into a soluble, protease-resistant form in the presence or absence 
of OHL.   
 
3.3. Results 
 
 In previous studies, we identified a set of genes that are directly regulated by 
CepR (Wei et al., 2011).  In an effort to identify additional members of this regulon, we 
cultured the cepI mutant strain CLW101 in the presence and absence of 1 µM OHL, and 
screened for differential gene expression using oligonucleotide microarrays.  This strain 
contains a PcepI-lacZ fusion that was created by an insertion of Tn5lac in cepI (Weingart 
et al., 2005), which allows us to test for induction.  The microarray included probes 
complementary to E. coli lacZ mRNA. Cultures containing OHL expressed 100-200 fold 
more β-galactosidase than identical cultures lacking OHL (Table 3.1).  OHL caused a 
3.2-3.5 fold increase in lacZ mRNA abundance as measured by the microarrays (Table 
3.1).  These data indicate that the microarrays reflected expression of this gene but show 
a compressed induction ratio.  Another CepR-regulated operon composed of aidA and 
aidB, was also strongly induced by OHL (Table 3.1).  
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 In this transcriptional profiling experiment, we also detected OHL-inducible 
expression of a number of additional genes (Table 3.1), including several that are closely 
linked to cepR2.  Interestingly, all of the OHL-inducible genes linked to cepR2 were 
previously found to be expressed more strongly in a cepR2 mutant than in a wild type 
strain (Malott et al., 2009).  The two studies taken together could suggest that apo-CepR2 
represses these genes, and that its ability to repress them is somehow antagonized by 
OHL.  These genes are expressed in six apparent operons (Fig. 3.1), including cepR2 and 
another possible regulatory gene cepS (both of which are monocistronic).  The operon 
containing bcam0184-0186 and the divergent bcam0187 were induced rather weakly 
compared to the others and were not pursued in the present study.  We focus first on the 
promoters of the bcam0191-0190 operon and of the divergent the bcam0192-0196 
operon.  Later, we will describe the regulation of cepR2 and cepS. 
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Table 3.1.  Transcriptional profiles of cells cultured in the presence or absence of 1 µM 
OHL.a 
  OHL Induction Ratio (S.D.)  
Gene  Trial 1 Trial 2 Average 
cepR2 vs. WT 
(Malott et al., 
2009) 
Alternate Name,  
Comments, References 
       
lacZ  3.51  (0.81) 3.24  (0.32) 3.38 n.a.b cepI-lacZ reporter 
bcal0510  7.61  (1.58) 6.41  (0.46) 7.01 n.d.c 
CepR-regulated (Wei 
et al., 2011) 
bcal0831  1.66  (0.20) 2.88  (0.81) 2.27 n.d. 
 bcal0833  0.87  (0.15) 1.29  (0.28) 1.08 n.d. phbB 
bcal2118  1.55  (0.24) 3.56  (0.93) 2.55 n.d. 
 bcal3178  1.49  (0.41) 3.09  (0.54) 2.29 n.d. 
 bcam0030  2.63  (1.41) 5.36  (2.27) 3.99 n.d. 
 bcam0031  2.57  (1.21) 4.48  (3.18) 3.52 n.d. 
 bcam0184  1.34  (0.28) 4.06  (3.23) 2.70 n.d. Lectin 
bcam0185  1.43  (0.45) 11.8  (1.96) 6.59 n.d. Lectin 
bcam0186  3.12  (0.40) 1.81  (0.52) 2.46 2.9 (0.8) bclA (lectin) 
bcam0187  0.99  (0.22) 3.24  (0.32) 2.12 n.d.  
bcam0188  2.45  (0.99) 2.62  (0.69) 2.53 21.1 (3.4) cepR2 
bcam0189  1.03  (0.26) 2.15  (0.46) 1.59 188 (46) cepS 
bcam0190  2.00  (0.81) 3.25  (0.54) 2.62 11.6 (0.9) 
Aminotransferase 
Class III 
bcam0191  1.96  (0.37) 4.11  (1.24) 3.04 9.5 (3.0) 
Non-ribosomal 
peptide synthase 
bcam0192  4.92  (1.24) 4.63  (2.79) 4.78 113 (27) 
Conserved 
hypothetical 
bcam0193  3.08  (1.28) 6.15  (1.73) 4.62 171 (74) 
Conserved 
hypothetical 
bcam0194  7.46  (1.69) 5.18  (1.70) 6.32 151 (48) 
Conserved 
hypothetical 
bcam0195  3.41  (1.76) 6.60  (1.33) 5.00    58.3 (62) 
Non-ribosomal 
peptide synthase 
bcam0196  7.08  (3.02) 3.50  (3.19) 5.29 80.5 (31) 
Conserved 
hypothetical 
bcam0393  2.45  (0.89) 3.34  (1.43) 2.90 n.d. 
 bcam0634  3.59  (0.08) 2.64  (0.15) 3.12 n.d. 
 bcam1413a  3.58  (1.60) 3.50  (3.19) 3.54 n.d. aidC (Wei et al., 2011) 
bcam1742  1.86  (0.65) 2.60  (1.10) 2.23 n.d. 
 
bcam1869  1.86  (0.65) 3.26  (1.23) 2.56 n.d. 
CepR-regulated (Wei 
et al., 2011) 
bcam2307  2.96  (0.60) 7.09  (3.23) 5.02 -1.7 ± (0.7) zmpB 
bcam2308  2.00  (0.57) 2.31  (0.85) 2.15 n.d. 
 bcas0153  2.34  (0.42) 1.78  (0.21) 2.06 n.d. 
 
bcas0292  14.9  (11.8) 39.4  (41.2) 27.2 n.d. 
aidB, CepR-regulated 
(Wei et al., 2011) 
bcas0293  293   (299) 198   (156) 245 1.7 ± (0.2) 
aidA, CepR-regulated 
(Wei et al., 2011) 
bcas0409  2.31  (0.60) 2.64  (0.67) 2.47 1.6 ± (0.3) zmpA 
 
 
     All Genes  1.00  (1.26) 1.00  (1.37) 1.00 
  a.    Strain CLW101 contains a chromosomal PcepI-lacZ fusion (Weingart et al., 2005).  In Trial 1 the 
culture lacking OHL expressed 2.7 Miller units of β-galactosidase, while the culture containing 
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OHL expressed 290 units.  In Trial 2, the culture lacking OHL expressed 1.5 units, while the 
culture containing OHL expressed 195 units. 
 
b. Not applicable 
 
c. Not determined 
 
 
 
3.3.1. Regulation of bcam0191 and bcam0192 by CepR2 and CepS   
 
 In order to study the bcam0191 and bcam0192 promoters more closely, we fused 
each to lacZ on a low copy plasmid.  Plasmid pGR130 contains the bcam0191 promoter 
on a 493 nucleotide fragment (Fig. 3.1), while plasmid pGR136 contains the bcam0192 
promoter on a 527 nucleotide fragment.  Expression of these fusions was tested in strains 
containing or lacking cepR2 or cepS, and in the presence or absence of exogenous OHL.  
All strains lacked cepI, and so they did not synthesize OHL. 
 
A cepR2+ strain expressing the bcam0191-lacZ fusion (pGR130) expressed 35 
units of β-galactosidase in the absence of OHL (Table 3.2).  This fusion was induced 
approximately 11-fold by OHL, in reasonable agreement with the transcriptional 
profiling experiments described above.  This fusion was also expressed 11-fold more 
strongly in a strain lacking CepR2 than in a CepR2+ strain, in agreement with the data of 
the Malott study (Malott et al., 2009).  Addition of OHL did not stimulate expression in 
the strain lacking CepR2 (Table 3.2).  These data are consistent with the hypothesis that 
the bcam0191 promoter is repressed by CepR2 and that repression is somehow 
antagonized by OHL.   
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 As described above, the cepS gene is adjacent to cepR2, and encodes a possible 
transcription factor of the AraC family.  The genetic linkage of cepS to cepR2, 
bcam0191, and bcam0192 suggested a possible role in their regulation.  We therefore 
deleted cepS and tested for the expression of the bcam0191-lacZ fusion in this mutant.  
Loss of cepS caused a severe decrease in expression of this promoter, both in the 
presence and absence of OHL (Table 3.2).  The lack of stimulation by OHL in a cepS 
mutant indicates that when CepR2 is inactive and CepS is absent, expression is very low.  
In other words CepS is epistatic to CepR2. 
 
Similar results were obtained from the divergent bcam0192 promoter (Table 3.2).  
In a strain expressing CepR2, the fusion in pGR136 was expressed 11-fold more strongly 
in the presence of OHL than in its absence.  In a strain lacking CepR2, the fusion was 
expressed 12-fold more strongly than in the presence of apo-CepR2 (Table 3.2) and was 
unaffected by OHL.  The cepS mutant expressed this promoter at low levels that were 
unaffected by OHL.  Evidently, the bcam0192 promoter is repressed by apo-CepR2 and 
activated by CepS, similar to the bcam0191 promoter.   
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Fig. 3.1.  Resections of the bcam0191 and bcam0192 promoters.  Chromosomal 
organization of OHL-inducible genes is indicated using gray arrows.  Genes are named in 
accordance with the genome sequence of strain J2315 (Holden et al., 2009).  Promoter-
proximal portions of the bcam0191 and bcam0192 genes are indicated using hatched 
boxes.  Endpoints of each resection are calculated with respect to the translation start site 
of regulated gene. The solid black box represents the CepR2 binding site. A promoterless 
β-galactosidase gene is denoted using a white box labelled “lacZ”.  
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Table 3.2.  Regulation of the promoters of bcam0191 and bcam0192 by CepR2, CepS, 
and OHL. 
Fusiona Chromosomal genotypeb Plasmid genotype OHL 
(uM) 
β-Galactosidase Normalized 
Valuesc 
bcam0191 WT none 0 35 ± 8  (1) 
 WT none 1 377 ± 30 10.8 
 GR141 (cepR2-) pSRKKm 0 383 ± 24 10.9 
 GR141 (cepR2-) pSRKKm 1 397 ± 32 11.3 
 GR141 (cepR2-) pGR192 (cepR2) 0 33 ± 4 0.95 
 GR141 (cepR2-) pGR192 (cepR2) 1 387 ± 21 11.1 
 GR145 (cepS-) pSRKGm 0 5 ± 3 0.14 
 GR145 (cepS-) pSRKGm 1 3 ± 2 0.1 
 GR145 (cepS-) pGR193 (cepS) 0 41 ± 8 1.2 
 GR145 (cepS-) pGR193 (cepS) 1 412 ± 32 11.8 
      
bcam0192 WT none 0 32 ± 3   (1) 
 WT none 1 362 ± 15 11.3 
 GR141 (cepR2-) pSRKKm 0 376 ± 31 11.8 
 GR141 (cepR2-) pSRKKm 1 368 ± 25 11.5 
 GR141 (cepR2-) pGR192 (cepR2) 0 36 ± 1 1.1 
 GR141 (cepR2-) pGR192 (cepR2) 1 373 ± 24 11.7 
 GR145 (cepS-) pSRKGm 0 3 ± 1 0.1 
 GR145 (cepS-) pSRKGm 1 4 ± 2 0.13 
 GR145 (cepS-) pGR193 (cepS) 0 43 ± 1 1.3 
 GR145 (cepS-) pGR193 (cepS) 1 396 ± 36 12.4 
a:   A bcam0191-lacZ transcriptional fusion was provided by pGR130, while a bcam0192-lacZ fusion 
was provided using pGR136.  The vector for both plasmids, pYW302, expressed only 1-2 units of 
β-galactosidase activity. 
 
b: All strains are derived from K56-I2, which carries an insertion mutation in cepI.   
 
c:  β-galactosidase activity is normalized to that of the wild type strain carrying the indicated plasmid 
and cultured in the absence of OHL. 
 
3.3.2. Reconstitution of regulated expression in a heterologous host.  	  
 We sought to determine whether CepR2 and CepS regulate the bcam0191 and 
bcam0192 promoters directly, and therefore attempted to reconstitute regulated 
expression in E. coli.  Plasmid pGR130 was introduced into derivatives of MC4100 
containing plasmids that express CepR2 and/or CepS.  In a strain expressing neither 
CepR2 nor CepS, the bcam0191-lacZ fusion expressed approximately 120 units of β-
galactosidase and was not significantly affected by OHL (Table 3.3).  The fusion was 
repressed approximately 4-fold by CepR2.  Surprisingly, OHL had little or no effect on 
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CepR2-mediated repression.  CepS enhanced expression of the fusion about 2.5 fold in 
the presence or absence of OHL.  When both proteins were provided in the absence of 
OHL, expression fell to the same levels as with CepR2 alone (Table 3.3).  However, 
when OHL was provided, expression increased to the same levels as with CepS alone.  
Very similar data were obtained using E. coli strains expressing the bcam0192-lacZ 
fusion (Table 3.3).  The ability of CepR2 and CepS to regulate expression of these 
promoters in E. coli indicates that they both are likely to act directly upon them.   
 
Table 3.3.  Regulated expression of the bcam0191 and bcam0192 promoters in E. colia.   
Fusionb 
Plasmids expressing B. cenocepacia 
genes 
OHL 
(uM) 
β-Galactosidase 
Activity 
Normalized 
Valuec 
bcam0191 none 0 121 ± 11 (1) 
 None 1 137 ± 15 1.13 
 pGR192 (cepR2) 0 29 ± 8 0.24 
 pGR192 (cepR2) 1 35 ± 8 0.29 
 pGR276 (cepS) 0 310 ± 21 2.6 
 pGR276 (cepS) 1 305 ± 17 2.5 
 pGR192 (cepR2), pGR276 (cepS) 0 35 ± 8 0.29 
 pGR192 (cepR2), pGR276 (cepS) 1 307 ± 30 2.5 
     
bcam0192 None 0 101 ± 11 (1) 
 None 1 93 0.92 
 pGR192 (cepR2) 0 23 ± 4 0.23 
 pGR192 (cepR2) 1 32 ± 3 0.32 
 pGR276 (cepS) 0 300 ± 11 3.0 
 pGR276 (cepS) 1 344 ± 23 3.4 
 pGR192 (cepR2), pGR276 (cepS) 0 32 ± 3 0.32 
 pGR192 (cepR2), pGR276 (cepS) 1 293 ± 30 2.9 
a: All strains were derived from MC4100. 
 
b:   A bcam0191-lacZ transcriptional fusion was provided by pGR130, while a bcam0192-lacZ fusion 
was provided using pGR136.   
 
c:   β-galactosidase activity is normalized to that of the wild type strain carrying the indicated plasmid 
and cultured in the absence of OHL. 
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3.3.3. Localization of DNA sequences required for regulated gene expression of 
bcam0191 and bcam0192.   	  
 The intergenic region between bcam0191 and bcam0192 start codons is 396 
nucleotides in length, and contains a strongly AT-rich region characteristic of many 
bacterial promoters.  In order to identify the essential sequences required for regulated 
expression of bcam0191, we made several resections of this promoter from its 5’ end 
(Fig. 3.1) and fused the remaining sequences to lacZ.  Plasmids pGR132, pGR195, 
pGR133, and pGR134 resemble pGR130, but contain 207, 184, 128, and 90 nucleotides 
upstream of the bcam0191 translation start site, respectively.  Plasmid pGR236 contains 
sequences from nucleotides -395 to -26 (Fig. 3.1).  The fusion in pGR132 was expressed 
at 3-fold higher levels than that of pGR130 in the absence of OHL, while the two fusions 
were expressed at similar levels in the presence of OHL (Table 3.4).  Both fusions were 
expressed at equally high levels in the absence of CepR2 and at equally low levels in a 
cepS mutant.  Similar data were obtained using pGR195 and pGR236.  Together, 
sequences required for OHL-responsive expression are limited to nucleotides -184 to -27.  
 
 The fusion of pGR133 was expressed at equally high levels in the presence or 
absence of OHL (Table 3.4), and was not affected by a CepR2 mutation (Table 3.4).  It 
was expressed at very low levels in a cepS mutant.  These data indicate that pGR133 
lacks some sequence required for repression by CepR2.  Plasmid pGR195 contains all 
such sequences and is 59 nucleotides longer than pGR133 at the 5’ end.   
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Table 3.4. Regulation of resected bcam0191 promoters by CepR2, CepS, and OHLa. 
Plasmid Fragment  Genotype OHL (uM) β-Galacto-
sidase 
Normalized 
Valueb 
pGR130 -395  −  +98 WT 0 35 ± 8  (1) 
  WT 1 377 ± 30 10.8 
  GR141 (cepR2-) 0 381 ± 30 10.9 
  GR141 (cepR2-) 1 365 ± 17 10.4 
  GR145 (cepS-) 0 7 ± 1 0.2 
  GR145 (cepS-) 1 2 ± 0 0.01 
pGR132 -207  −  +98 WT 0 94 ± 27 (1) 
  WT 1 361 ± 34 3.8 
  GR141 (cepR2-) 0 327 ± 28 3.5 
  GR141 (cepR2-) 1 349 ± 31  3.7 
  GR145 (cepS-) 0 9 ± 1 0.1 
  GR145 (cepS-) 1 7 ± 1 0.07 
pGR195 -184  −  +98 WT 0 74 ± 13 (1) 
  WT 1 361 ± 35 4.9 
  GR141 (cepR2-) 0 326 ± 28 4.4 
  GR141 (cepR2-) 1 389 ± 31 5.3 
  GR145 (cepS-) 0 n.d. n.d. 
  GR145 (cepS-) 1 n.d. n.d. 
pGR133 -128  −  +98 WT 0 339 ± 9 (1) 
  WT 1 361 ± 20 1.1 
  GR141 (cepR2-) 0 339 ± 29 1.0 
  GR141 (cepR2-) 1 360 ± 11 1.1 
  GR145 (cepS-) 0 1 ± 1 0.003 
  GR145 (cepS-) 1 1 ± 1 0.002 
pGR134 -90  −  +98 WT 0 10 ± 2 (1) 
  WT 1 6 ± 4 1.0 
  GR141 (cepR2-) 0 9 ± 4 1.0 
  GR141 (cepR2-) 1 10 ± 3 1.0 
  GR145 (cepS-) 0  2 ± 1 0.2 
  GR145 (cepS-) 1 2 ± 1 0.2 
pGR236 -395  −  -27 WT 0 45 ± 6    (1) 
  WT 1 248 ± 26 5.5 
  GR141 (cepR2-) 0 248 ± 19 5.5 
  GR141 (cepR2-) 1 226 ± 20 5.0 
  GR145 (cepS-) 0 3.3 ± 1 0.07 
  GR145 (cepS-) 1 2.5 ± 1 0.06 
  
a:  Derivatives of strain K56-I2 containing the indicated cepR2 or cepS mutations and the indicated 
plasmids were grown to an optical density of approximately 0.4 in the presence or absence of 1 
µM OHL, and assayed for β-galactosidase activity.  Data are the averages of three biological 
replicates, with standard deviations indicated.   
 
b:   β-galactosidase activity is normalized to that of the wild type strain carrying the indicated plasmid 
and cultured in the absence of OHL. 
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 The fusion of pGR134 was expressed at low levels in all backgrounds and was not 
responsive to OHL.  This plasmid therefore lacks sequences required for promoter 
expression, either the promoter itself or the CepS binding site.  Plasmid pGR133 contains 
all sequences required of CepS-dependent expression and is 38 nucleotides longer (Fig. 
3.1). 
 
 We noticed an imperfect dyad symmetrical DNA sequence 
(GACAGCCCGATTTGCGGATGTC, symmetrical bases are underlined) present in all 
CepR2-repressed plasmids and absent or partially absent in all CepR2-nonresponsive 
ones.  To learn more about the role of this sequence in regulation, we constructed two 
additional plasmids (pGR197 and pGR198, Fig. 3.1 and Fig. 3.2).  The first plasmid 
contains this sequence plus 13 additional promoter-distal bases, while the second plasmid 
lacks five bases near the promoter-distal end of this sequence.  Plasmid pGR197 was 
induced by OHL in an E. coli strain expressing CepR2, while pGR198 was not affected 
(Fig. 3.2).  We used site-directed mutagenesis to alter small groups of nucleotides within 
this dyad symmetry.  Plasmids pGR259, pGR260, and pGR261 have 3- or 4-nucleotide 
mutations in the upstream half of this sequence.  All three mutations significantly reduced 
induction by OHL (Fig. 3.2), providing additional evidence that this dyad is essential for 
CepR2 activity.  We will demonstrate that this site is bound by CepR2 in vitro (see 
below). 
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Fig. 3.2.  Resections and alterations of the CepR2 binding site. The dyad symmetrical 
CepR2 binding site is indicated using inverted arrows.  All sequences shown were part of 
a bcam0191-lacZ fusion.  B. cenocepacia sequences are capitalized while vector 
sequences are shown in lower case.  Vector sequences that fortuitously match the original 
DNA sequence are capitalized.  Site-directed mutations of the CepR2 binding site are 
underlined.  β-galactosidase activity was determined for cells cultured in the presence or 
absence of OHL. 
 
 
 Similar experiments were carried out to identify cis-acting sites necessary for 
regulated expression of the divergent gene bcam0192.  Four plasmids, pGR137, pGR138, 
pGR139, and pGR140 were constructed that resemble pGR136 but have 324, 268, 202, 
or 114 nucleotides of upstream DNA, respectively (Fig. 3.1).  Plasmid pGR243 resembles 
pGR136 but contains sequences from nucleotides -400 to -47 (Fig. 3.1).  Significantly, 
pGR137 contains all of the dyad symmetry described above and 21 additional 
nucleotides, while pGR138 lacks half of the dyad, and pGR139 and pGR140 lack all of it.  
Plasmid pGR137 resembled pGR136 in that it was derepressed by OHL and by a cepR2 
mutation, and was expressed at very low levels in a cepS mutant (Table 3.5).   
Experiment 1 
 
pGR132  GCAATTCTTATCCTAGACAGCCCGATTTGCGGATGTCAATTCCGTGCGGTTTTGTTG   0     59!"      (1) 
                                                                    1    364!#$      6.2     
pGR197  GCAATTCTTATCCTAGACAGCCCGATTTGCGGATGTCAATTCCGTGCGGTggTaccG   0     55!%      (1) 
                                                                    1    376±32      6.8 
pGR198  GCAATTCTTATCCTAGACAGCCCGATTTGCGGggtaCcgagCtcgaattcaaTtCgc   0    418±34     (1) 
                                                                    1    396±21      0.95 
pGR133  GCAATTCTTATCCTAGACAGCCCGATggtaccgaGctcgaattcaattcggcgtTaa   0    339!9      (1) 
                                                                    1    437!24      1.3 
Experiment 2  
 
pGR197  GCAATTCTTATCCTAGACAGCCCGATTTGCGGATGTCAATTCCGTGCGGTggTaccG   0     33!%      (1) 
                                                                    1    224!&'      6.8 
pGR259  GCAATTCTTATCCTAGACAGCCCGATTTGCGGATCAGAATTCCGTGCGGTggTaccG   0    139!#(     (1) 
                                                                    1    245!&#      1.8 
pGR260  GCAATTCTTATCCTAGACAGCCCGATTTGCCCTAGTCAATTCCGTGCGGTggTaccG   0    147!#)     (1) 
                                                                    1    162!&%      1.1 
pGR261  GCAATTCTTATCCTAGACAGCCCGATAACGGGATGTCAATTCCGTGCGGTggTaccG   0     50!#(     (1) 
                                                                    1    158!&(      3.2 
OHL  
(uM) 
!-Galacto- 
sidase 
Induction 
Ratio 
	   82	  
Table 3.5.  Regulation of the promoter of bcam0192 by CepR2, CepS, and OHLa.   
Plasmid Fragment  Genotype OHL 
(uM) 
β-Galacto-
sidase 
Normalized 
Valueb 
pGR136 -400 − +126 WT 0 32 ± 3   (1) 
  WT 1 367± 30 11.5 
  GR141 (cepR2-) 0 376 ± 31 11.8 
  GR141 (cepR2-) 1 368 ± 25 1.0 
  GR145 (cepS-) 0 3 ± 1 0.1 
  GR145 (cepS-) 1 4 ± 2 0.01 
pGR137 -324 − +126 WT 0 78 ± 10 (1) 
  WT 1 357 ± 15 4.8 
  GR141 (cepR2-) 0 356 ± 23 4.6 
  GR141 (cepR2-) 1 374 ± 34   1.0 
  GR145 (cepS-) 0 7 ± 3 0.9 
  GR145 (cepS-) 1 5 ± 2 0.01 
pGR138 -268 − +126 WT 0 217 ± 23 (1) 
  WT 1 263 ± 15 1.2 
  GR141 (cepR2-) 0 374 ± 18 1.7 
  GR141 (cepR2-) 1 382 ± 23 1.7 
  GR145 (cepS-) 0 4 ± 2 0.02 
  GR145 (cepS-) 1 7 ± 3 0.03 
pGR139 -202 − +126 WT 0 370 ± 21 (1) 
  WT 1 375 ± 23 1.0 
  GR141 (cepR2-) 0 364 ± 26 1.0 
  GR141 (cepR2-) 1 384 ± 43 1.0 
  GR145 (cepS-) 0 12.5 ± 4 0.03 
  GR145 (cepS-) 1 18.7 ± 9 0.05 
pGR140 -114 − +126 WT 0 5 ± 7 (1) 
  WT 1 4 ± 9 0.8 
  GR141 (cepR2-) 0 8 ± 6 1.6 
  GR141 (cepR2-) 1 5 ± 3 1.0 
  GR145 (cepS-) 0 3 ± 2 0.7 
  GR145 (cepS-) 1 3 ± 1 0.7 
pGR243 -400 − -46 WT 0 75 ± 14 (1) 
  WT 1 332 ± 32 4.4 
  GR141 (cepR2-) 0 392 ± 32 5.2 
  GR141 (cepR2-) 1 421 ± 28 5.6 
  GR145 (cepS-) 0 2.4 ± 1.2 0.03 
  GR145 (cepS-) 1 5.6 ± 1.2 0.07 
a:  Derivatives of strain K56-I2 containing the indicated cepR2 or cepS mutations and the indicated 
plasmids were grown to an optical density of approximately 0.4 in the presence or absence of 1 
µM OHL, and assayed for β-galactosidase activity.  Data are the averages of three biological 
replicates, with standard deviations indicated.   
 
b:   β-galactosidase activity is normalized to that of the wild type strain carrying the indicated plasmid 
and cultured in the absence of OHL. 
 
 
 In contrast, the fusions in pGR138 and pGR139 were expressed at high levels and 
not significantly affected by CepR2 or OHL.  They were expressed at low levels in a 
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cepS mutant.  Plasmid pGR140 expressed its fusion at very low levels under all 
conditions.  Expression of the fusion of pGR243 was similar to wild type, indicating that 
all sequences required for regulation lie upstream of nucleotide -47.  These data suggest 
that the dyad symmetry is required for regulation of the bcam0192 promoter, just as it 
was for the divergent bcam0191 promoter.  In both cases, the repressor binding site 
appears to lie well upstream of the regulated promoters. 
 
3.3.4. Regulation of the cepR2 and cepS promoters 
 The microarray data described above shows that OHL may cause induction of 
cepR2 and cepS, though the effect is very slight.  In contrast, microarray data of Malott 
and colleagues indicate that both these genes are expressed far more strongly in a cepR2 
mutant than in a cepR2+ strain (Malott et al., 2009).  Although these data do not directly 
contradict ours, the two datasets are nonetheless somewhat difficult to reconcile.   
 
 In order to study the expression of the cepR2 and cepS genes further, we 
constructed two plasmids in which each promoter is fused to lacZ.  These plasmids were 
introduced into strains lacking one or the other of these genes, and cultured in the 
presence or absence of OHL.  Both fusions gave similar results.  In the strain containing 
cepR2 and cepS, expression was increased about 2-fold by OHL (Table 3.6).  Perhaps 
surprisingly, this slight increase also was detected in a cepR2 mutant, indicating that 
CepR2 is not required.  The cepS mutation caused a mild decrease in expression of both 
promoters, but did not affect the very slight stimulation by OHL.  These data tend to 
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support our microarray data.  In the Discussion, we will describe a possible explanation 
for the data of the Malott study. 
 
Table 3.6.  Regulation of the cepR2 and cepS promoters. 
Fusiona Fragmentb Chromosomal 
genotypec 
OHL (uM) β-Galactosidase Induction 
Ratio  PcepR2-lacZ -195  - +170 WT 0 237 ± 8 (1) 
  WT 1 480 ± 30 2.0 
  GR141 (cepR2-) 0 247 ± 23 1.0 
  GR141 (cepR2-) 1 446 ± 26 1.9 
  GR145 (cepS-) 0 116 ±13 0.5 
  GR145 (cepS-) 1 126 ± 12 0.5 
      
 PcepS-lacZ -198  - +127 WT 0 264 ± 23  (1) 
  WT 1 468 ± 35 1.8 
  GR141 (cepR2-) 0 237 ± 17 0.9 
  GR141 (cepR2-) 1 482 ± 32 1.8 
  GR145 (cepS-) 0 172 ± 14 0.7 
  GR145 (cepS-) 1 155 ± 21 0.6 
 
a:   The cepR2-lacZ fusion was carried by plasmid pGR141, while the cepS-lacZ fusion was 
carried by pGR146.   
b:  Coordinates of the two fusions are calculated relative to the cepR2 and cepS translation 
start sites, respectively. 
c: All strains are derivatives of K56-I2, and therefore have mutations in cepI. 
 
3.3.5. Specificity of CepR2 for AHL-type pheromones 	  
 Throughout this study, we have used strains that have null mutations in cepI, and 
have been providing exogenous OHL where indicated.  These strains still have cciI, and 
therefore presumably synthesize hexanoyl-HSL (HHL), and smaller amounts of similar 
pheromones.  The fact that OHL influences CepR2 indicates that CciI-synthesized AHLs 
do not activate this fusion, at least not fully.  However, they could in principle play some 
role in CepR2 function.  To address this question, we assayed the expression of a 
bcam0191-lacZ fusion in the presence of different AHL-type pheromones, with acyl 
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groups that vary in length and substitution.  Among these, OHL was the most effective at 
derepressing the fusion (Fig. 3.3).  The only other pheromone that showed significant 
activity was 3-oxooctanoyl-HSL (OOHL).   Decanoyl-HSL (DHL) showed a trace of 
activity when provided at high concentrations, while five other AHL pheromones 
(hexanoyl-HSL, 3-oxo-hexanoyl-HSL, 3-oxo-decanoyl, dodecanoyl-HSL, and 3-oxo-
dodecanoyl-HSL) were inactive (data not shown).  We conclude that endogenous levels 
of pheromones synthesized by CciI did not detectably impact CepR2 activity. 
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Fig. 3.3.  Detection of heterologous AHLs by CepR2. Strains K56-I2(pGR130) and K56-
I2(pGR136) were used to test the induction of the bcam0191 (A) and bcam0192 
promoters (B), respectively. β-galactosidase activity of cultures amended with selected 
concentrations of OHL (triangles), 3-oxooctanoyl-HLS (OOHL, squares), and decanoyl-
HSL (DHL, circles) were measured at mid-log growth.  The values shown are the mean 
standard deviation (error bars) from triplicate experiments. Five other AHLs (hexanoyl-
HSL, 3-oxo-hexanoyl-HSL, 3-oxo-decanoyl-HSL, dodecanoyl-HSL, and 3-oxo-
dodecanoyl-HSL) did not detectably induce expression of the fusion (data not shown).  
 
 
0 
100 
200 
300 
400 
0.1 1 10 100 1000 
AHL (nM) 
0 
100 
200 
300 
400 
0.1 1 10 100 1000 
AHL (nM) 
A 
(bcam0191) 
B 
(bcam0192) 
OHL 
OHL 
OOHL 
OOHL 
DHL 
DHL 
O O 
N 
O 
O H 
O 
O 
N 
O 
H 
	   87	  
3.3.6. Ability of cells expressing CepR2 to sequester AHLs  	  
 The hypothesis that CepR2 is antagonized by OHL and OOHL predicts that it 
should be able to bind these AHLs stably and preferentially.  To test this, we 
overexpressed CepR2 using the T7 promoter in E. coli in the presence of each of eight 
different AHLs, then washed the cells of each culture to remove unbound or weakly 
bound AHLs, and bioassayed for CepR2-bound AHLs.  Of the eight AHLs tested, OHL 
was detected at the highest levels, followed by OOHL and ODHL (3-oxodecanoyl-HSL) 
(Fig. 3.4).  Trace amounts of HHL and OHHL (3-oxohexanoyl-HSL) were bound, while 
DHL, dDHL and OdDHL (dodecanoyl-HSL and 3-oxododecanoyl-HSL) were not 
detectably sequestered.  These data agree fairly well with the preference for OHL in vivo 
as described above, except that DHL was more active then ODHL in the former assay, 
while ODHL was sequestered more effectively than DHL. It appears that ODHL can bind 
CepR2 without altering its DNA binding properties as profoundly as other AHLs. 
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Fig. 3.4.  Ability of CepR2 overproduced in E. coli to sequester eight different AHLs.  
E. coli strain BL21(DE3)(pGR107) was incubated in medium containing 10 nM of the 
indicated AHL.  Bound AHLs were extracted and bioassayed (Zhu et al., 1998).  The 
bioassay strain was calibrated using each AHL.  The values shown are the mean and 
standard deviations (error bars) and triplicate experiments. 
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 Several LuxR-type transcription factors that require AHLs for activity fail to fold 
into a soluble, protease resistant form in the absence of AHLs (Zhu & Winans, 1999, Zhu 
& Winans, 2001, Urbanowski et al., 2004, Schuster et al., 2004, Weingart et al., 2005).  
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soluble, protease resistant forms in the absence of their cognate pheromones (Tsai & 
Winans, 2011, Minogue et al., 2002, Castang et al., 2006).  Solubility of some LuxR-type 
proteins is also enhanced by artificial overexpression of the chaperone GroESL (Chai & 
Winans, 2009, Choi & Greenberg, 1992).  We assayed the accumulation of soluble 
CepR2 in the presence and absence of OHL, and in strains that express normal or 
elevated levels of GroESL.  CepR2 was detected in a soluble form only when GroESL 
was overproduced (Fig. 3.5).  The yield of soluble CepR2 may have been enhanced 
somewhat by OHL, but it was significantly soluble in the absence of OHL.  CepR2 
therefore resembles at least three other LuxR-type proteins that function as apo-proteins 
in that none requires its ligand for folding into a soluble form.  
 
 
 
Fig. 3.5.  Ability of CepR2 to fold into a soluble form requires GroESL but does not 
require OHL. E. coli strain BL21(DE3)(pGR107) containing or lacking pT7-GroESL was 
cultured in medium containing or lacking 1 µM OHL, lysed, and clarified extracts were 
size-fractionated by SDS-PAGE and stained using Coomassie Brilliant Blue. 
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3.3.8. Electrophoretic mobility shift assays with CepR2. 	  
 Data described above suggested that CepR2 binds to a dyad symmetrical DNA 
sequence in the intergenic region between bcam0191 and bcam0192.  We sought to 
obtain biochemical support for this hypothesis by carrying out electrophoretic mobility 
shift assays (EMSA) using radiolabelled DNA fragments containing this sequence.  
Clarified supernatants containing apo-CepR2 shifted a DNA fragment containing 83 
nucleotides of DNA that contains this sequence (Fig. 3.6, Fragment 2) under conditions 
including a 10,000-fold excess non-specific competitor DNA.  The extract containing 
apo-CepR2 did not shift two fragments containing nearby sequences (Fragments 1 and 3).  
We also tested two fragments identical to Fragment 2 (denoted Fragments 4 and 5) that 
contained either a 3-nucleotide or 4-nucleotide alterations in the dyad sequence (Fig. 3.6, 
bottom panel).  Binding affinity was greatly weakened with these mutant DNA 
fragments, although residual binding was detectable.   
 
 The data described above using fusions indicates that CepR2 is antagonized by 
OHL and suggests that its ability to bind DNA might be antagonized by OHL.  To test 
this, we set up binding reactions using Fragment 2, apo-CepR2, and a range of OHL 
concentrations.  As predicted, OHL inhibited DNA binding by CepR2 (Fig. 3.6, right 
panel). 
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Fig. 3.6.  Electrophoretic mobility shift assays of fragments containing the CepR2 
binding site.  A: location and size of DNA fragments used in Part B. B. Clarified 
supernatants containing CepR2 were used for all binding reactions. A 65-bp PCR 
amplified lacZ DNA fragment was used as a negative control (open arrowhead).  Free 
DNA is indicated using a black arrowhead, while CepR2-DNA complexes are indicated 
using a grey arrowhead. CepR2 supernatants were diluted 3.16-fold in reactions with 
DNA fragments in the absence of OHL (gels 1-5). In gel 6, binding reactions containing 
CepR2 and Fragment 2 were amended with OHL to final concentrations of 0 µM, 0.032 
µM, 0.1 µM, 0.315 µM, and 1.0 µM. C. Sequence of fragments containing the wild type 
CepR2 binding site (Fragment 2) or near-identical fragments having the indicated 
sequence alterations (Fragments 4 and 5).  The dyad symmetrical CepR2 binding site is 
boxed, and altered sequences are underlined.  
 
	   92	  
 Earlier in this study we provided evidence that CepR2 does not autoregulate, nor 
does it regulate cepS.  Supporting these conclusions, CepR2 did not detectably shift a 
DNA fragment containing the cepR2-cepS intergenic region.  
 
3.3.9. DNase I footprinting of the CepR2 binding site. 	  
 In order to further localize the CepR2 binding site, we carried out DNase I 
footprinting experiments using fluorescently end-labeled DNA fragments containing this 
sequence.  Clarified supernatants containing apo-CepR2 protected a region of 
approximately 20 nucleotides that contains this dyad symmetry (Fig. 3.7).  On the basis 
of promoter resections, point mutations, EMSA, and DNase I footprinting, we conclude 
that CepR2 binds specifically to this dyad DNA sequence. 
 
3.3.10. Identification of the transcription start sites of bcam0191 and bcam0192. 	  
 In an effort to identify possible transcription start sites for the two promoters, we 
isolated total mRNA from strain K56-I2 cultured in the presence or absence of OHL and 
hybridized it with a 5’ fluorescently labeled oligonucleotide complementary to bcam0191 
mRNA, and in a separate reaction, did the same experiment using an oligonucleotide 
complementary to bcam0192 mRNA.  These oligonucleotides were used as primers for 
DNA synthesis by reverse transcriptase, and resulting cDNA transcripts were size-
fractionated by automated capillary electrophoresis.   
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Fig. 3.7.  DNase I protection of the CepR2 binding site by CepR2.  A fluorescently end-
labeled DNA fragment was combined with a clarified extract containing CepR2 (second 
and fourth panel) or an extract lacking CepR2 (first and third panel), partially digested 
with DNase I, and size fractionated by automated capillary electrophoresis. The bottom 
two panels are enlargements of the left third of the top two panels.  The DNA sequence of 
the protected region is shown at the bottom.  The CepR2 binding site is indicated using 
inverted arrows, and symmetrical nucleotides are underlined.  Nucleotides are numbered 
with respect to the 5’- end of fluorescently-labeled amplicon. 
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 Using the former primer, the major reverse transcripts were 61, 62, and 63 
nucleotides in length, corresponding to apparent start sites lying 54, 55, and 56 
nucleotides upstream of the bcam0191 translation start site (Fig. 3.8).  Upstream of these 
sites are sequences that resemble the -10 and -35 motifs of proteobacterial vegetative 
promoters.  The promoter motif and apparent starts sites are 
ATGAAAN17TATTTTTTATTAAA, where single underlined sequences resemble 
consensus promoters, and the double underlines indicate the three apparent transcription 
start sites.  Plasmid pGR134 contains this putative promoter with no additional upstream 
sequences.  It expresses this promoter at very low levels, suggesting that it may lack a 
binding site for CepS.  The CepR2 binding site is centered 75 nucleotides upstream of 
this putative transcription start site.   
 
 Using the fluorescent primer that hybridizes to bcam0192 mRNA, we detected 
several reverse transcripts ranging in size from 40 to 53 nucleotides (Fig. 3.8).  These 
correspond to apparent transcription start sites between and 112 and 126 nucleotides 
upstream of the bcam0192 translation start site.  Upstream of these apparent start sites is 
the sequence TTGAATN19TATTTAGCATCGACGCCTGAAA, where single underlined 
sequences resemble consensus promoters, and the double underlines indicate the apparent 
transcription start sites.  The positioning of a promoter motif with respect to the three 
candidate start sites suggests that the middle candidate, a G residue, may represent the 
true transcription start site.  The CepR2 binding site is centered 150 nucleotides upstream 
from this putative transcription start site. 
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Fig. 8.  Localization of the bcam0191 and bcam0192 promoters by primer extension of 
mRNA.  Total RNA was purified from strain K56-I2 cultured in the absence (B and D) or 
presence (A and C) of 1 µM OHL. Oligonucleotides GR458 and GR459 were used to 
prime reverse transcription of bcam0191 and bcam0192 mRNA, respectively, and the 
resulting cDNA fragments were size-fractionated by automated capillary electrophoresis.  
Sizes are relative to the 5’ ends of the two fluorescently labeled primers. 
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3.4. Discussion 
 
CepR2 is active only as an apo-protein 
 This study was initiated while trying to reconcile microarray data of our lab with 
that of another group.  Malott and colleagues showed that a strain lacking CepR2 
overexpressed a number of genes tightly linked to cepR2 (Malott et al., 2009), while we 
had found that OHL stimulated the expression of an overlapping set of genes.  The 
hypothesis that CepR2 was a repressor whose activity was blocked by a cognate 
pheromone seemed worth exploring, as most LuxR-type proteins require a cognate AHL 
for activity.  The only known exceptions are the VjbR protein of Brucella melitensis and 
a clade of proteins that resemble EsaR of P. stewartii (Tsai & Winans, 2010, Delrue et 
al., 2005). 
 
 Our data confirm that CepR2 is antagonized by OHL, making it similar to VjbR 
and to members of the EsaR clade.  EsaR-type proteins are relatively closely related, and 
may therefore have evolved from a common ancestor that had similar properties.  
However, EsaR-type proteins are not closely related to CepR2 or to VjbR.  CepR2 and 
VjbR are also only distantly related.  These data suggest that the ability of these proteins 
to function only as apo-proteins may have evolved at least three times independently.  It 
seems quite plausible that more LuxR-type proteins will turn out to be AHL-inhibited 
rather then AHL-stimulated. 
 
 The study of Malott and colleagues provided data that CepR2, when expressed in 
E. coli, activated the luxI promoter in the absence of any AHL (Malott et al., 2009).  
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Activation was not affected by addition of ten different AHLs, including OHL.  It was  
concluded that CepR2 does not detect AHLs.  The ability of CepR2 to function in the 
absence of AHLs agrees well with our findings.  The lack of inhibition by AHLs is also 
reminiscent of some of the data in the current study.  CepR2, when expressed in E. coli, 
repressed both the bcam0191 and bcam0192 promoters whether or not OHL was 
provided (Table 3.3).  OHL-responsiveness was restored only when CepS was co-
expressed.  In both studies, CepR2 was expressed by fusing the cepR2 gene to the Plac 
promoter.  We believe that in both studies, CepR2 may inadvertently have been 
overexpressed.  If so, perhaps this overexpression may overcome the inhibitory activity 
of OHL.  One could imagine that CepR2 binds DNA only as a dimer, that OHL weakens 
dimerization, and the overexpression of CepR2 may shift the equilibrium toward dimers, 
such that enough dimers exist to populate the binding site and repress transcription (in 
our study) or activate transcription (in the Malott study). 
 
CepR2 acts as a repressor 
 Although EsaR-type members of the LuxR family are sometimes referred to as 
repressors, at least some of them can act as both repressors and activators, depending 
largely on the position of their binding sites relative to the target promoter.  For example 
EsaR is both an autorepressor and an activator of a divergent gene, esaS (Schu et al., 
2011).  YenR also is an activator of a small RNA gene (Tsai & Winans, 2011).  In the 
present study, CepR2 was demonstrated to act as a repressor.  However, it is plausible 
that it could also activate one or more other promoters in this organism.  The fact that 
CepR2 can activate the luxI promoter of V. fischeri in a system reconstituted in E. coli 
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provides further evidence that it could act as an activator in B. cenocepacia.  Malott and 
colleagues reported that the cepR2 mutation caused decreased expression of 127 genes, 
though the effects were generally modest (Malott et al., 2009).  
 
 Efforts to reconstitute regulated expression of these promoters in E. coli were met 
with some success and a few surprises.  CepR2 inhibited expression of both promoters, 
and CepS activated both, just as they did in B. cenocepacia, strongly suggesting that they 
act directly.  The expression of both promoters in the absence of these proteins was far 
higher in E. coli than in B. cenocepacia, probably due at least in part to a ColE1 
replication origin in the reporter plasmid that functions to produce high copy number in 
E. coli but which is inactive in B. cenocepacia.  It was initially surprising that OHL did 
not seem to block CepR2 repression, though these results were rationalized as due to 
CepR2 overproduction.  The fact that OHL-responsiveness was restored by CepS could 
be due to synergistic effects of OHL and CepS.  
 
Regulation of cepR2 and cepS. 
 In the present study, we found that the divergent cepR2 and cepS genes were very 
slightly up-regulated by OHL in transcriptional profiling experiments.  Fusions between 
these promoters and lacZ confirmed these results, and showed curiously, that the effect 
was CepR2-independent.  One possibility is that this regulation is mediated by CepR, 
although the induction is so slight as to be of unknown significance.  Both promoters 
were also downregulated by a mutation in cepS, though once again, the effect was subtle. 
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 In another study, a mutation in cepR2 was described as causing a large increase in 
the expression of cepR2 and of cepS (Malott et al., 2009) .  We believe that the apparent 
discrepancy between those data and ours could be due to cis-acting effects of the cepR2 
mutation used in the Malott study.  In that study, the cepR2 null mutation was constructed 
using a trimethoprim resistance cassette inserted near the 5’ end of cepR2.  Significantly, 
this cassette has two divergent promoters (DeShazer & Woods, 1996).  We believe that 
transcription from one promoter continued into cepR2 while transcription from the other 
promoter continued into cepS.  If so, the mutant would express both genes at higher 
levels than the wild type, exactly as reported.  However, the implication that this 
enhanced expression occurred that the native promoters of the two genes would have to 
be re-evaluated.  If we are right that the cepR2 mutation caused increased expression of 
cepS, the increased accumulation of CepS protein could have implications for the 
expression of all CepS-dependent promoters described in the Malott study. 
 
Identity of a secondary metabolite 
 The functions of the regulated genes remain a matter for speculation.  Analysis of 
these protein sequences suggests a role in synthesizing a secondary metabolite.  The N-
terminal half of Bcam0195 is predicted to bind ATP and leucine, while the C-terminal 
half contains a phosphopantatheine binding site and a reductase domain.  bcam0191 is a 
condensation domain while Bcam0190 is an aminotransferase.  Based on these 
homologies, one could hypothesize that this pathway could convert a yet unknown ketone 
into an amine, condense it to leucine, and then reduce the dipeptide into a terminal 
aldehyde.  Further chemistry probably could occur on the reactive aldehyde (Michael 
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Burkart, personal communication).  We are currently collaborating in an attempt to purify 
such a metabolite and identify its structure.   
 
Opposing roles for CepR2 and CepS.   
 The two CepR2-repressed promoters that we examined are unusual in that the 
repressor binding site appears to lie upstream of the regulated promoters.  In the case of 
bcam0191, the binding site is centered 75 nucleotides upstream of the transcription start 
site.  In the case of bcam0192, the binding site is centered 150 nucleotides upstream.  
Promoter resections confirm that the CepR2 binding site lies well upstream of both 
promoters.  This is atypical of most repressible promoters, as repressor binding sites 
generally lie within the target promoter or directly downstream (Perez-Rueda et al., 
1998).  We believe that this unusual promoter geometry can be explained only in the 
context of CepS, a positive regulator of both promoters.  Data obtained from promoter 
resections can be used to predict the region of the CepS binding site.  We have several 5’ 
resections that are blind to CepR2 yet are still CepS-dependent, indicating that CepS must 
bind downstream of CepR2.  This binding site must lie fully within plasmid pGR133, but 
may be fully or partly absent in pGR134.  These plasmids contain 75 and 37 nucleotides 
of DNA upstream of the bcam0191 transcription start site, respectively.  These data 
strongly suggest that CepS binds DNA between the promoter and the CepR2 binding site. 
 
 A cepS mutant expressed both promoters at very low levels irrespective of OHL 
status.  This indicates that when CepS is absent, CepR2 has no effect on expression of 
these promoters.  In other words, CepS appears to work downstream of CepR2, and 
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CepR2 appears to act by inhibiting CepS activity.  One possibility is that CepR2 binding 
sterically blocks CepS binding, and that OHL, by blocking CepR2 activity, allows CepS 
to bind and activate the two promoters.  If so, there must be two CepS binding sites, as 
plasmid pGR133 and pGR138, which share no B. cenocepacia DNA, have two different 
CepS-dependent promoters and therefore two different CepS binding sites.   Interestingly, 
when CepR2 and CepS function were reconstituted in E. coli, CepR2 was able to 
decrease expression even in the absence of CepS, while this was not true in B. 
cenocepacia.  It seems possible therefore that CepR2 may regulate these promoters in 
two ways, one dependent on CepS, and one that is independent.   
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Fig. 3.9.  A model of proposed activities of CepR2 and CepS.  In this model, apo-
CepR2 binds to a single site between the bcam0191 and bcam0192 promoters. Bound 
CepR2 inhibits the stimulatory activity of CepS, which binds between CepR2 and the 
two target promoters.  At high-cell density, OHL accumulates and releases CepR2 
from the DNA, permitting CepS to activate both promoters. CepR2 thus functions as 
an antiactivator of CepS.  
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The interactions of the CepR2 repressor and the CepS activator are somewhat reminiscent 
of the CytR repressor and CAP activator of E. coli, which function antagonistically at 
several promoters (Shin et al., 2001, Tretyachenko-Ladokhina et al., 2006, Valentin-
Hansen et al., 1996).  CytR binds to a site centered 70 nucleotides upstream of the deoP2 
promoter, flanked by two binding sites for CAP, one centered at -40.5 and the other at -
93.5.  Binding of CytR does not dislodge CAP, but may block the proper positioning of 
the C-terminal domain of the alpha subunit of RNA polymerase (RNAP).  By analogy, 
apo-CepR2 could act by blocking the interactions between CepS and RNAP (Fig. 3.9).  
Equally plausibly, CepR2 might simply block the binding of CepS to a site near these 
promoters. 
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3.5. Experimental Procedures. 
 
Strains, oligonucleotides, and growth conditions.  
Bacterial strains and plasmids used in this study are listed in Tables 3.7 and 3.8.  
Oligonucleotide primers (IDT, Coralville, Iowa) used for PCR amplification and DNA-
mutagenesis are listed in Table 3.9. Burkholderia cenocepacia and Escherichia coli were 
cultured at 37°C in Luria-Bertani (LB) medium and Agrobacterium tumefaciens was 
cultured at 28°C in AT minimal medium.  Antibiotics were added where described at the 
following concentrations: 100 µg ml-1 ampicillin, 100 µg ml-1 kanamycin, 35 µg ml-1 
chloramphenicol, and 12 µg ml-1 tetracycline for E. coli; 300 µg ml-1 tetracycline, 700 µg 
ml-1 kanamycin, 400 µg ml-1 gentamicin for B. cenocepacia; 100 µg ml-1 spectinomycin 
and 35 µg ml-1 tetracycline for A. tumefaciens. Media was supplemented with 500 µM 
isopropyl β-d-galactopyranoside (IPTG) where indicated.  
Transcriptional activity of bcam0191 and bcam0192 promoters.   
Recombinant DNA techniques were performed using standard methods (Sambrook & 
Russell, 2001). The intergenic region containing promoter and regulatory elements for 
each divergent promoter was resected by PCR amplification.  For each resection, the 
amplicon was cloned into the promoter-less transcriptional lacZ reporter plasmid 
pYWN302 at KpnI and XbaI sites creating a transcriptional reporter fusion.  Reporter 
fusion plasmids were transformed into B. cenocepacia or E. coli strain MC4100 by 
electroporation (Cangelosi et al., 1991).  To assay promoter activity, overnight cultures 
were diluted to 1:100 into LB medium and grown at 37°C to an OD600 of 0.35 with the 
appropriate antibiotics and 1 µM OHL.  Cultures aliquots (150 µL) were transferred to 
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the wells of opaque microtitre plates containing 4 µl of a 1.5 mg/ml solution of 4-
methylumbelliferyl-β-D-galactopyranoside (MUG) dissolved in DMSO.  β-galactosidase 
specific activities were measured using a Biotek Synergy HT microplate fluorescence 
reader.  Experiments were performed in triplicate with three different isolates of each 
strain. 
 
 To construct a plasmid expressing a regulated Plac-cepR2 fusion, the cepR2 gene 
was cloned into the pSRKKm broad-host range vector (Khan et al., 2008) to create 
pGR192.  This promoter is regulated by LacIq encoded on the plasmid and is induced 
with IPTG.  pSRKGm was used to construct plasmid pGR193 which expresses an IPTG-
inducible cepS gene. Constitutive expression of CepS was obtained by cloning the cepS 
gene into plasmid pSW208 to create pGR276. 
 
 Mutations of the putative cepR2 box were made by PCR amplification using 
oligonucleotide primers containing mutagenic oligonucleotides.  The PCR fragments 
were cloned into the transcriptional reporter vector pYWN302 that had been digested 
with KpnI and XbaI. 
Construction of deletion mutations in cepR2 and cepS.   
To create an internal deletion cepR2 mutant, oligonucleotides GR329 and GR330 were 
used to PCR amplify a 741-nucleotide fragment upstream of cepR2, while 
oligonucleotides GR331 and GR332 were used to PCR amplify a 737-nucleotide 
fragment downstream of cepR2.  These fragments were digested with EcoRI, ligated, and 
PCR amplified using oligonucleotides GR329 and GR332, creating a 1.5 kb fragment 
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with a 633 nucleotide deletion of cepR2 (nucleotides 21-652 of the cepR2 reading frame).  
This fragment was digested using HindIII and XbaI and ligated into pEX18Tet-pheS 
(Barrett et al., 2008), and introduced into strain SM10(λpir) by transformation, creating 
pGR178.  This plasmid was introduced into B. cenocepacia K56-I2 by conjugation.  
Tetracycline-resistant single-crossover recombinant mutants were screened by PCR for 
correct integration of the plasmid and double crossover recombinants were selected using 
M9 agar supplemented with 0.1% p-chlorophenylalanine (Sigma-Aldrich) (Barrett et al., 
2008).  The resulting colonies were screened by PCR amplification for the 633 nucleotide 
cepR2 deletion and verified by DNA sequencing (Cornell Biotechnology Resource 
Center).  The resulting cepR2 deletion was designated GR141.   
 
 A similar strategy was used to delete cepS.  Oligonucleotides GR345 and GR346 
were used to amplify a 474-nucleotide fragment upstream of cepS, while GR347 and 
GR348 were used to PCR amplify a 492-nucleotide fragment downstream of cepS.  These 
fragments were digested with SpeI, and PCR amplified using oligonucleotides GR345 
and GR348, yielding a 0.95 kb fragment that contains a 0.9 kb deletion of cepS.  This 
fragment was digested using BamHI and EcoRI and ligated into pEX18Tet-pheS, to 
create pGR182.  The cepS deletion was crossed into the genomic DNA of strain K56-I2 
as described above, creating strain GR145. 
AHL detection by CepR2.  
To measure CepR2 AHL ligand specificity, strains K56-I2(pGR130) and K56-
I2(pGR136), was cultured at 37°C to mid-log phase (OD600 0.4) in 2 ml LB medium 
supplemented with tetracycline and AHLs at concentrations ranging from 1 pM to 1 µM. 
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Promoter activity was determined by measuring β-galactosidase activity as described 
above. Experiments were performed in triplicate. 
Overexpression of CepR2.  
To overexpress CepR2 in E. coli, the cepR2 gene was PCR amplified using 
oligonucleotides GR295 and GR288 and inserted into pRSETa (Invitrogen) after 
digesting both with NdeI and XhoI, creating pGR107.  E. coli strain BL21 (DE3) 
(Novagen) harboring plasmids pGR107 and pT7-groESL (which expresses the chaperone 
GroESL) were grown in LB medium supplemented with 0.4% glucose, 400 µg ml-1 
ampicillin and 35 µg ml-1 chloramphenicol at 37°C.  At an OD600 of 0.4, cultures were 
cooled to 28°C and 10 µM OHL was added as indicated. Protein expression was induced 
using 0.5 mM IPTG and growth was continued for three additional hours at 28°C. Cells 
were harvested and resuspended in TEDG buffer (50 mM Tris-HCl pH 8.0, 1 mM EDTA, 
1 mM DTT, 20% glycerol) supplemented with 200 mM NaCl.  Cells were disrupted 
using a French press (three passages, 10,000 psi) and the lysate was clarified by 
ultracentrifugation (50,000 r.p.m., 30 min, 4°C). Protein fractions were analyzed on SDS-
PAGE gels stained with Coomassie blue. 
AHL sequestration assays. 
E. coli strain BL21(DE3)(pGR107) was used to test for the sequestration of AHLs.  Cells 
were cultured at 18°C in 10 ml LB medium supplemented with 100 µg ml-1 ampicillin.  
When the OD600 reached 0.4, IPTG was added to a final concentration of 0.5 mM, and 
AHLs were added at a final concentration of 10 µM.  When the cultures reached an 
OD600 of 0.7 (approximately 4 hours), they were  harvested, washed twice with LB, then 
washed three times with TE buffer (10 mM Tris (pH 8), 0.5 mM EDTA) and resuspended 
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in lysis buffer (200 mM Tris (pH 8), 400 mM EDTA, 0.7 mM sucrose).  Cell-associated 
autoinducers were extracted twice with ethyl acetate:acetonitrile (99.5:0.5 v/v) (HPLC 
grade, Fisher).  Organic phase extracts were pooled and dried under nitrogen gas.  Pellets 
were resuspended in 10 µl ethyl acetate and added to cultures inoculated with the 
biosensor strain A. tumefaciens WCF47(pCF218)(pCF372), which detects a wide range 
of AHLs (Zhu et al., 1998).  The detection of each AHL was calibrated using known 
concentrations of each AHL.  Cultures were grown for 12 h at 28° and assayed for β-
galactosidase specific activity.  Experiments were performed in triplicate. 
Electrophoretic mobility shift assays.  
For all EMSA reactions, a clarified supernatant from BL21(DE3)(pGR107)(pT7-groESL) 
was dialyzed against EMSA buffer (50 mM Tris-HCl pH 7.0, 2 mM EDTA, 2 mM DTT, 
60 µM potassium acetate, 39 µM potassium glutamate, 20% glycerol). DNA fragments 
were PCR amplified using oligonucleotides described in Table 3.9 and end-labeled with 
T4 polynucleotide kinase and [γ-32P]-ATP (Perkin Elmer). Binding reactions contained 
2.5 pM of DNA and varying concentrations of CepR2 protein in a 15 µl total volume 
containing EMSA buffer, 20 µg ml-1 of calf thymus DNA, and 20 µg ml-1 of BSA.  
Reactions were incubated at room temperature for 30 minutes, and complexes were size-
fractionated at 4°C using 10% polyacrylamide gels (Dgel Sciences) containing 20 mM 
Tris-acetate pH 8.5, and 1 mM EDTA (0.5 x TAE).  Gels were analyzed using a Storm 
B840 Phosphorimager (Molecular Dynamics).  All reactions were performed in triplicate. 
DNase I protection assay 
A fluorescently labeled 84-bp fragment was PCR amplified using primers GR280 and 
GR458 (Table 3.9). Binding reactions contained ~ 200 ng DNA and a clarified 
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supernatant of strain BL21(DE3)(pGR107)(pT7-groESL) (10 mg ml-1 total protein) or 
BSA (for control) diluted in 20 µl EMSA buffer and incubated at room temperature for 
30 minutes.  MgCl2 (2.5 mM), CaCl2 (0.5 mM) and 0.1 units of DNase I (Ambion) were 
added to the reaction and allowed to incubate at room temperature for 2.5 minutes. The 
reaction was stopped by addition of 0.75 µl stop solution (20 mM EDTA (pH 8.0), 200 
mM NaCl, 1% SDS).  DNA was purified with the Qiagen PCR kit and eluted in 20 µl 
water. DNA fragments were analyzed using an Applied BioSystems 3730xl DNA 
Analyzer (Cornell University Life Sciences Core Laboratories Center). 
Primer extension assays 
Strain K56-I2 was cultured to mid-log phase in LB with or without 1 µM OHL at 37°C. 
DNA-free mRNA preparations were isolated from 2 ml cell culture aliquots using Qiagen 
RNeasy Plus Mini kit. Residual DNA in mRNA extracts was degraded using Turbo 
DNA-free kit (Applied Biosystems) and mRNA was purified by isopropanol 
precipitation. cDNA transcripts containing bcam0191 and bcam0192 transcriptional start 
sites were obtained with the Superscript III RT kit (Invitrogen) using GR458 or GR459 
fluorescently labeled primers, respectively. cDNA transcripts were purified (Qiagen PCR 
purification kit) and DNA fragment analysis was performed as above. 
All reactions were performed in triplicate. 
Transcriptional profiling.  
Whole genome microarray slides containing 3-5 different probes for each gene of the B. 
cenocepacia genome were purchased from Agilent (AMADID #016249).  Bacterial 
strains were cultured to exponential phase in AT minimal medium and subjected to RNA 
extraction as described previously (Cho & Winans, 2005). Preparation of fluorescent 
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cDNA was performed following a published procedure (Hegde et al., 2000).  
Hybridization and washing of slides was performed according to the manufacturer’s 
protocol. Fluorescence intensity was analyzed using a GenePix 400B scanner (Axon).  
Induction ratios were calculated after normalization with locally weighted linear 
regression (lowess) analysis.  Experiments were performed in duplicate, with independent 
bacterial culturing, RNA preparation, cDNA probe synthesis, dye coupling and 
hybridizations.  The Cy3 and Cy5 dyes were swapped in the two trials. 
 
Table 3.7. Bacterial strains used in this study.   
Strain Description Source and/or 
reference B. cenocepacia  
K56-I2 B. cenocepacia K56-2 cepI::TpR (Lewenza et al., 
1999) GR141 K56-I2, ΔcepR2, cepI::TpR This study 
GR145 K56-I2, ΔcepS, cepI::TpR This study 
   
E. coli  
DH5α F- φ80lacZ∆M15 ∆(lacZYA-argF) U169 recA1 endA1 hsdR17 (rk-, mk+) 
phoA supE44 λ-thi-1 gyrA96 relA1 
Stratagene 
BL21(DE3) Plac-gene 1 of bacteriophage T7; pTet-TVMV protease, KmR (Studier et al., 
1990) MC4100 F- araD139 Δ(argF-lac)U169 rpsL150 relA1 deoC1 rbsR fthD5301 
fruA25 λ- 
(Ferenci et al., 
2009) SM10(λpir) λpir, RP4 tra regulon, host for pir-dependent plasmids; KanR (Donnenberg & 
Kaper, 1991) EPMax10B F−mcrA Δ(mrr-hsdRMS-mcrBC) 80dlacZΔM15 ΔlacX74 deoR recA1 
endA1 araD139 Δ(ara, leu)7697 galU galK rpsL nupG λ− 
(Barrett et al., 
2008)    
Agrobacterium tumefaciens 
WCF47(pCF218) 
(pCF372) 
R10 ΔtraI; PtetR-traR, PtraI-lacZ fusion; TetR, SpR (Fuqua & Winans, 
1994)    
 
Table 3.8. Plasmids used in this study.   
Plasmid Description Source and/or 
reference 
pRSETa T7 promoter cloning vector, ColE1 ori, ApR Invitrogen 
pT7-groESL PT7-groESL, ColE1; CmR (Yasukawa et al., 
1995) 
pYWN302 Broad host range, promoterless transcriptional lacZYA reporter, TetR (Wei et al., 2011) 
pSRKGm pBBR1MCS-2-derived broad-host range expression vector containing lac 
promoter; Gm 
(Khan et al., 2008) 
pSRKKm pBBR1MCS-2-derived broad-host range expression vector containing lac 
promoter; KanR 
(Khan et al., 2008) 
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pEX18Tet-pheS Suicide plasmid for gene replacement based on pheS and TetR (Barrett et al., 
2008) 
pSW208 pACYC184-derived plasmid containing lac promoter; CmR Lab collection 
pGR107 cepR2 cloned into NdeI and XhoI sites of pRSETa using oligonucleotides 
GR295 and GR288. 
This study 
pGR130 PCR fragment using oligonucleotides GR283 and GR284 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0191-lacZ fusion. 
This study 
pGR132 PCR fragment using oligonucleotides GR280 and GR284 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0191-lacZ fusion. 
This study 
pGR133 PCR fragment using oligonucleotides GR281 and GR284 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0191-lacZ fusion. 
This study 
pGR134 PCR fragment using oligonucleotides GR279 and GR284 cloned into 
pYWN302 KpnI and XbaI sites; bcam0191-lacZ fusion 
This study 
pGR136 PCR fragment using oligonucleotides GR196 and GR191 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0192-lacZ fusion. 
This study 
pGR137 PCR fragment using oligonucleotides GR195 and GR191 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0192-lacZ fusion 
This study 
pGR138 PCR fragment using oligonucleotides GR194 and GR191 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0192-lacZ fusion 
This study 
pGR139 PCR fragment using oligonucleotides GR193 and GR191 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0192-lacZ fusion 
This study 
pGR140 PCR fragment using oligonucleotides GR192 and GR191 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0192-lacZ fusion. 
This study 
pGR141 PCR fragment using oligonucleotides GR197 and GR202 cloned into 
pYWN302 at KpnI and XbaI sites; cepR2-lacZ fusion. 
This study 
pGR146 PCR fragment using oligonucleotides GR203 and GR208 cloned into 
pYWN302 at KpnI and XbaI sites; cepS-lacZ fusion. 
This study 
pGR178 PCR fragment made using GR329, GR330, GR331, and GR332, cloned 
into pEX18Tet-pheS; cepR2 deletion with flanking DNA  
This study 
pGR182 PCR fragment made using GR345, GR346, GR347, and GR348 cloned 
into pEX18Tet-pheS; cepS deletion with flanking DNA. 
This study 
pGR192 pSRKKm derivative containing cepR2 using GR288 and GR295. This study 
pGR193 pSRKGm derivative containing cepS using GR322 and GR323 This study 
pGR195 PCR fragment using oligonucleotides GR292 and GR284 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0191-lacZ fusion 
This study 
pGR197 PCR fragment using oligonucleotides GR293 and GR284 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0191-lacZ fusion 
This study 
pGR198 PCR fragment using oligonucleotides GR294 and GR284 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0191-lacZ fusion 
This study 
pGR236 PCR fragment using oligonucleotides GR275 and GR283 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0191-lacZ fusion 
This study 
pGR243 PCR fragment using oligonucleotides GR196 and GR380 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0192-lacZ fusion 
This study 
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pGR259 PCR fragment using oligonucleotides GR392 and GR284 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0191-lacZ fusion with altered 
CepR2 binding site 
This study 
pGR260 PCR fragment using oligonucleotides GR393 and GR284 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0191-lacZ fusion with altered 
CepR2 binding site 
This study 
pGR261 PCR fragment using oligonucleotides GR394 and GR284 cloned into 
pYWN302 at KpnI and XbaI sites; bcam0191-lacZ fusion with altered 
CepR2 binding site 
This study 
pGR276 pSW208 derivative containing cepS using GR323 and GR417 This study 
 
 
Table 3.9.  Oligonucleotides used in this study. 
Name Sequence Comments 
GR191 ATTTCTAGACGAATACGTGCCATTCCATG 
For PCR amplifying bcam0192 promoters in 
pGR136, pGR137, pGR138, pGR139, and 
pGR140 and Fragment 3. 
GR192 ATTGGTACCCTGAAATTGCTGC 
For PCR amplifying of bcam0192 promoter in 
pGR140. 
GR193 ATTGGTACCTGGATGGATGAGGAGTCTG For PCR amplifying Fragment 3 and pGR139  
GR194 ATTGGTACCTTGCGGATGTCAATTCC 
For PCR amplifying of bcam0192 promoter in 
pGR138.  
GR195 ATTGGTACCTCGCATCGTGCATTTC 
For PCR amplifying of bcam0192 promoter in 
pGR137. 
GR196 ATTGGTACCTCACGTCGTTTCTCCTG 
For PCR amplifying bcam0192 promoter in 
pGR136 and pGR243 
GR197 ATTTCTAGACGACGATCTGCATGTCG For PCR amplifying cepR2 promoter in pGR141 
GR202 ATTGGTACCGTCGATCAGTCCTGATAC For PCR amplifying cepR2 promoter in pGR141 
GR203 ATTGGTACCCATACTCGTGAGCAAGC For PCR amplifying cepS promoter in pGR146 
GR208 ATTTCTAGAATCGGTGATCCTCG For PCR amplifying cepS promoter in pGR146 
GR275 GCTTCTAGAGGTGGATGAATTAAATGC 
For PCR amplifying bcam0191 promoter in 
pGR236 
GR279 ATTGGTACCATGAAATGCACGATGCG 
For PCR amplifying bcam0191 promoter in 
pGR134 
GR280 ATTGGTACCCCTCATCCATCCATCAA 
For PCR amplifying bcam0191 promoter in 
pGR132 
GR281 ATTGGTACCATCGGGCTGTCTAGGATAAG 
For PCR amplifying bcam0191 promoter in 
pGR133 
GR283 ATTGGTACCGGACTCTCCTAGTAATGTCC 
For PCR amplifying bcam0191 promoter in 
pGR130, pGR236. 
GR284 ATTTCTAGAGCGTAGATATGCGTCGAC 
For PCR amplifying bcam0191 promoters in 
pGR130, pGR132, pGR133, pGR134, pGR195, 
pGR197, pGR198, pGR259, pG260, pGR261 
and Fragment 1.  
GR288 ATTCTCGAGTTTTTCACGTCACGG 
For amplifying cepR2 for cloning into pGR107 
and pGR192 
GR292 ATTGGTACCTACTGGAAAGGCTTTGACGCA 
For PCR amplifying bcam0191 promoter in 
pGR195 
GR293 ATTGGTACCCGCACGGAATTGACATC For PCR amplifying bcam0191 promoter in 
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pGR197 
GR294 ATTGGTACCCCGCAAATCGGGCTGTC 
For PCR amplifying bcam0191 promoter in 
pGR198 
GR295 GGAATTCCATATGGACCTGACAATACTG 
For amplifying of cepR2 for cloning into pGR192 
and pGR107 
GR301 CCTCTTCGCTATTACGCCAGC 
For PCR amplifying of lacZ fragment for negative 
control for EMSA experiments 
GR302 CGTTACCCAACTTAATCG 
For PCR amplifying of lacZ fragment for negative 
control for EMSA experiments 
GR322 GGAATTCCATATGACCAGCGTTCAAGACG For PCR amplifying cepS for cloning into pGR193 
GR323 CCCAAGCTTGATCGTGCATGCGATC 
For PCR amplifying cepS for cloning into pGR193 
and pGR276. 
GR324 GATCGTGCATGCGATC For sequence verification of cepR2 deletion 
GR328 GCATGCGTCTTGTTCATCGC For sequence verification of cepS deletion  
GR329 ACTAAGCTTCTGCAGTCGCTCGCACAGCTT 
With GR330, GR331, and GR332, for 
construction of cepR2 deletion fragment cloned 
into pGR178. 
GR330 ATTGAATTCTTGCAGTATTGTCAGGTCCATC 
With GR329, GR331, and GR332, for 
construction of cepR2 deletion fragment cloned 
into pGR178. 
GR331 ATTGAATTCTCGACGCGATGAACAAGAC 
With GR329, GR330, and GR332, for 
construction of cepR2 deletion fragment cloned 
into pGR178. 
GR332 ACTTCTAGAGCACGTACGATTCGATCATTCGC 
With GR329, GR330, and GR331, for 
construction of cepR2 deletion fragment cloned 
into pGR178. 
GR345 ATGGATCCGAACGCATTCCATACGACC 
With GR346, GR347, and GR348, for 
construction of cepS deletion fragment cloned 
into pGR182. 
GR346 GCACTAGTGATCAGTCCTGATACGAAACCG 
With GR345, GR347, and GR348, for 
construction of cepS deletion fragment cloned 
into pGR182.. 
GR347 GCACTAGTGATCGCATGCACGATCCG 
With GR345, GR346, and GR348, for 
construction of cepS deletion fragment cloned 
into pGR182.. 
GR348 CGGAATTCGACATCATGTGCTTGGC 
With GR345, GR346, and GR347, for 
construction of cepS deletion fragment cloned 
into pGR182.. 
GR351 ATTTCTAGACATATTCGCATCGTGCATTTC For PCR amplifying Fragments 2, 4, and 5 
GR365 ATTTCTAGAGGATAAGAATTGCGATTCATC For PCR amplifying Fragment 1 
GR380 ATTTCTAGATTCCGGCGCCGGAAACCGTTT 
For PCR amplification of bcam0192 promoter in 
pGR243 
GR391 
ATGGTACCCGCACGGAATTGACATCCGCAA 
ATCGGGCTGTC For PCR amplifying Fragment 2 
GR392 
ATGGTACCCGCACGGAATTCTGATCCGCAA 
ATCGGGCTGTC 
For PCR amplification of bcam0191 promoter in 
pGR259 and Fragment 4 
GR393 
ATGGTACCCGCACGGAATTGACTAGGGCAAA 
TCGGGCTGTC 
For PCR amplification of bcam0191 promoter in 
pGR260 and Fragment 5 
GR394 
ATGGTACCCGCACGGAATTGACATCCCGTT 
ATCGGGCTGTC 
For PCR amplification of bcam0191 promoter in 
pGR261  
GR417 
ATGAATTCAGGAGGCGATAGATGACCAGCG 
TTCAAGA 
For PCR amplifying cepS and cloning into 
pGR276 
GR458 6-FAM-ATCGGTCACGTCGTTTCTCC 
For mapping bcam0191 promoter and DNA 
footprinting analysis  
GR459 6-FAM-AATTGCCTGCATGCCGT For mapping bcam0192 promoter 
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Chapter 4: Conclusions and a brief comparison of CepR and CepR2 
 
4.1. Decoding of the respective binding sites by CepR and CepR2 
 
 
 In Chapter 2, the consensus binding sequence for CepR was identified and the 
contributions of each nucleotide to binding affinity and specificity were determined. The 
18-bp consensus sequence was defined by a five-nucleotide palindrome that flanks a 
variable four-nucleotide spacer around the dyad axis. Each half-box contributed five 
nucleotides required for CepR specificity and mutations to any nucleotide resulted in 
defective phenotype (Fig. 2.3). In contrast, nucleotides within the spacer region were 
better tolerated by CepR and did not greatly alter DNA binding recognition. Furthermore, 
new gene promoters directly regulated by CepR contained cep box motifs with strong 
agreement to the consensus sequence. This suggests that the highly conserved symmetric 
bases are predicted to be involved in CepR-DNA interactions. The features of the cep box 
are similar to other well-defined LuxR-type binding sites that each contains conserved 
dyad nucleotides separated by a non-symmetrical spacer region (Fig. 4.1). The individual 
regions appear to contribute to different interactions made by the protein at its respective 
binding site. TraR makes sequence-specific contacts with six bases within the conserved 
region of each half-site of the tra box, while sequence-independent contacts are made at 
nucleotides within the central spacer (Zhang et al., 2002).  
 
 A look at the binding site for the second B. cenocepacia LuxR-type regulator, 
CepR2, reveals the sequence is defined by similar features and contains four palindromic 
nucleotides flanking seven non-symmetrical nucleotides. Binding affinity and promoter 
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activity for this binding site also required sequence-specific recognition by CepR2, 
though mutations of the palindromic nucleotides were more defective than those made at 
positions with imperfect symmetry (Fig. 3.2). Additional mutations are needed to further 
identify all the bases critical for sequence-specific interaction within the cepR2 box. 
Given the similarity in binding site characteristics and phenotypes for mutations at 
nucleotides within the dyad, it is predicted that residues within CepR and CepR2 C-
terminal domain (CTD) would make similar contacts at critical bases within their 
respective DNA binding sites. Scanning alanine mutagenesis would permit the analysis of 
important amino acid residues involved in direct contact of both regulators with their 
respective binding sites.   
 
 .  
 
Figure 4.1. Alignment of the left half of the binding sites for LuxR, TraR, 
CepR, and CepR2, respectively. Palindromic nucleotides are bolded.  
 
 
 It was hypothesized that the width of the cep box central spacer, whose spacer 
region is two nucleotides larger than that of the tra box, would result in a higher angle 
DNA bend when bound by CepR compared to TraR at the tra box. Indeed, CepR was 
found to induce a 45° bend at this site. There appears to be a correlation between the 
width of the central spacer and the magnitude of the DNA bend conferred by the LuxR-
type protein. It is interesting to consider the implications of this for CepR2 at its binding 
CTGTAGGAT lux box (consensus) 
tra box (consensus) ATGTGCAGA 
cep box (consensus) CCCTGTAAGA 
cepR2 box (Pbcam0191) GACAGCCCGAT 
half box sequence LuxR-type binding 
site
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site, given that the cepR2 box spans more than 2-helical turns.  It is possible that CepR2 
will cause a sharper bend.  Alternatively, CepR2-cepR2 box interaction may be 
constrained by a particular CepR2 conformation. That is, the absence of OHL may impart 
a flexibility in the CTD that can accommodate the span of the 22-nt binding site not 
possessed in the OHL-bound CepR2 structure.  These two hypotheses can be tested by 
determining the DNA angle bend and shed insight into the CepR2 interaction with its 
binding site.  If the former is true and apo-CepR2 contorts the DNA around its structure, 
the DNA bend angle would be expected to be greater than that observed in CepR at its 
binding site.  If the latter is true and CepR2 affinity to the cepR2 box is determined by the 
OHL-induced structural conformation, than the bend angle would be expected to be less 
than 45°. 
 
4.2. Effect of OHL on CepR2 expression and function 
 
 In Chapter 3, CepR2 was shown to act as a repressor and interact with its DNA 
binding site in the absence of its cognate signal, OHL. This requires the protein to stably 
accumulate at low cell density when OHL levels are low. Accumulation of soluble 
CepR2 was found to be independent of OHL but required co-expression of the chaperone, 
GroESL, supporting this assertion. As discussed above, CepR2 recognized its DNA site 
through sequence-specific interactions; however, it is unclear how binding of the 
autoinducer signal alters this affinity for this site. 
 Comparison of amino acid alignments highlight structural differences between the 
apo-active regulators in the γ-proteobacteria and those from other classes, and include an 
extended linker region between the AHL-binding domain and an extended C-terminus 
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(Fig. 4.2). The importance of this linker region on translating the signal to the CTD is not 
understood. EsaR protein stability and multimeric state of both full-length and an EsaR-
NTD subunit were recently reported to be unaffected by autoinducer binding (Schu et al., 
2011). It is postulated that binding of AHL may be translated to the CTD and result in 
DNA-binding prohibitive conformational changes. This leads to interesting questions 
about the role of autoinducer binding on the dimerization of individual domains. 
However, CepR2 does not possess this linker and therefore, it is unclear whether the 
insights gained from the EsaR experiments are relevant to the mechanism of CepR2 
regulation. Preliminary experiments, including western immunoblots and pulse-chase, are 
needed to address questions about the effect of OHL binding on CepR2 stability and 
accumulation in the cell. The role of dimerization on DNA recognition also needs to be 
addressed. It would be interesting to determine if CepR2-CTD subunits are functional 
independent of the NTD. If that is the case, the CTD domain could then be probed for 
mutations that inhibited functional DNA binding. 
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Figure 4.2. Protein alignment of LuxR-type C-terminal domain sequences using the solved TraR model as 
the template. TraR, LuxR, CepR, CepR2, YenR, EsaR, and ExpR are involved in quorum sensing in A. 
tumefaciens, E. carotovora, V. fischeri, B. cenocepacia, Y. enterocolitica, and P. stewartii, respectively. 
Identical and conserved residues are shaded in black and grey, respectively. Position of TraR residues are 
numbered above the sequence. Bases directly interacting with TraR residues are denoted by an asterix. 
Predicted alpha helices are denoted by black lines under the alignment. Protein domains are shown as boxes 
below the sequence: N-terminal domain, hatched box; C-terminal domain, black box. 
 
  
  
 Regulation of gene expression for divergent NRPS promoters was found to be 
dependent on CepR2 and CepS activity. Negative regulation is mediated by CepR2 in the 
absence of OHL. The site of this repression, cepR2 box, is located distal to both 
promoters and predicted CepS activation sites. CepS is required for positive regulation 
and is predicted to bind DNA at separate sites located between the cepR2 box and the 
respective promoter elements for each gene. CepS-mediated activation is independent of 
both OHL and CepR2, indicating that CepS is epistatic to CepR2.  Apo-CepR2 is 
predicted to act as an anti-activator of CepS. Apo-CepR2 may act by obstructing access 
of CepS to the DNA or may bind adjacent to CepS and alter CepS activity through 
protein-protein interactions.  Preliminary studies, using DNase I protection assay and 
additional promoter resections, will be useful in determining the DNA binding site of 
CepS. 
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